﻿<?xml version="1.0" encoding="utf-8"?>
<Return xmlns="http://www.irs.gov/efile" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.irs.gov/efile" returnVersion="2023v5.1">
  <ReturnHeader binaryAttachmentCnt="0">
    <ReturnTs>2024-11-14T12:00:02-06:00</ReturnTs>
    <TaxPeriodEndDt>2023-12-31</TaxPeriodEndDt>
    <PreparerFirmGrp>
      <PreparerFirmEIN>130436940</PreparerFirmEIN>
      <PreparerFirmName>
        <BusinessNameLine1Txt>ANCHIN BLOCK &amp; ANCHIN LLP</BusinessNameLine1Txt>
      </PreparerFirmName>
      <PreparerUSAddress>
        <AddressLine1Txt>3 TIMES SQUARE</AddressLine1Txt>
        <CityNm>NEW YORK</CityNm>
        <StateAbbreviationCd>NY</StateAbbreviationCd>
        <ZIPCd>10036</ZIPCd>
      </PreparerUSAddress>
    </PreparerFirmGrp>
    <ReturnTypeCd>990PF</ReturnTypeCd>
    <TaxPeriodBeginDt>2023-01-01</TaxPeriodBeginDt>
    <Filer>
      <EIN>474685449</EIN>
      <BusinessName>
        <BusinessNameLine1Txt>DAFTUAR FAMILY FOUNDATION</BusinessNameLine1Txt>
      </BusinessName>
      <BusinessNameControlTxt>DAFT</BusinessNameControlTxt>
      <PhoneNum>2122730462</PhoneNum>
      <USAddress>
        <AddressLine1Txt>CO PRA LLC 450 LEX AVE 38TH FL</AddressLine1Txt>
        <CityNm>NEW YORK</CityNm>
        <StateAbbreviationCd>NY</StateAbbreviationCd>
        <ZIPCd>10017</ZIPCd>
      </USAddress>
    </Filer>
    <BusinessOfficerGrp>
      <PersonNm>BALDO FODERA</PersonNm>
      <PersonTitleTxt>MANAGER</PersonTitleTxt>
      <PhoneNum>2122730462</PhoneNum>
      <SignatureDt>2024-11-13</SignatureDt>
      <DiscussWithPaidPreparerInd>1</DiscussWithPaidPreparerInd>
    </BusinessOfficerGrp>
    <IRSResponsiblePrtyInfoCurrInd>0</IRSResponsiblePrtyInfoCurrInd>
    <PreparerPersonGrp>
      <PreparerPersonNm>JARED FELDMAN</PreparerPersonNm>
      <PTIN>P01334565</PTIN>
      <PhoneNum>2128403456</PhoneNum>
      <PreparationDt>2024-11-13</PreparationDt>
    </PreparerPersonGrp>
    <TaxYr>2023</TaxYr>
    <BuildTS>2024-10-15 13:58:12Z</BuildTS>
  </ReturnHeader>
  <ReturnData documentCnt="12">
    <IRS990PF documentId="RetDoc1235000001">
      <Organization501c3ExemptPFInd>X</Organization501c3ExemptPFInd>
      <FMVAssetsEOYAmt>77887984</FMVAssetsEOYAmt>
      <MethodOfAccountingCashInd>X</MethodOfAccountingCashInd>
      <AnalysisOfRevenueAndExpenses>
        <ContriRcvdRevAndExpnssAmt>15164772</ContriRcvdRevAndExpnssAmt>
        <InterestOnSavRevAndExpnssAmt>34267</InterestOnSavRevAndExpnssAmt>
        <InterestOnSavNetInvstIncmAmt>34267</InterestOnSavNetInvstIncmAmt>
        <DividendsRevAndExpnssAmt>845709</DividendsRevAndExpnssAmt>
        <DividendsNetInvstIncmAmt>827525</DividendsNetInvstIncmAmt>
        <NetGainSaleAstRevAndExpnssAmt>-868336</NetGainSaleAstRevAndExpnssAmt>
        <GrossSalesPriceAmt>10229936</GrossSalesPriceAmt>
        <CapGainNetIncmNetInvstIncmAmt>7396613</CapGainNetIncmNetInvstIncmAmt>
        <OtherIncomeRevAndExpnssAmt referenceDocumentId="RetDoc2001500001">-521</OtherIncomeRevAndExpnssAmt>
        <OtherIncomeNetInvstIncmAmt>-910</OtherIncomeNetInvstIncmAmt>
        <TotalRevAndExpnssAmt>15175891</TotalRevAndExpnssAmt>
        <TotalNetInvstIncmAmt>8257495</TotalNetInvstIncmAmt>
        <CompOfcrDirTrstRevAndExpnssAmt>332770</CompOfcrDirTrstRevAndExpnssAmt>
        <CompOfcrDirTrstNetInvstIncmAmt>0</CompOfcrDirTrstNetInvstIncmAmt>
        <CompOfcrDirTrstDsbrsChrtblAmt>332770</CompOfcrDirTrstDsbrsChrtblAmt>
        <OthEmplSlrsWgsRevAndExpnssAmt>675744</OthEmplSlrsWgsRevAndExpnssAmt>
        <OthEmplSlrsWgsNetInvstIncmAmt>0</OthEmplSlrsWgsNetInvstIncmAmt>
        <OthEmplSlrsWgsDsbrsChrtblAmt>674752</OthEmplSlrsWgsDsbrsChrtblAmt>
        <PensionEmplBnftRevAndExpnssAmt>149464</PensionEmplBnftRevAndExpnssAmt>
        <PensionEmplBnftNetInvstIncmAmt>0</PensionEmplBnftNetInvstIncmAmt>
        <PensionEmplBnftDsbrsChrtblAmt>149464</PensionEmplBnftDsbrsChrtblAmt>
        <LegalFeesRevAndExpnssAmt referenceDocumentId="RetDoc2002100001">29091</LegalFeesRevAndExpnssAmt>
        <LegalFeesNetInvstIncmAmt>0</LegalFeesNetInvstIncmAmt>
        <LegalFeesDsbrsChrtblAmt>29091</LegalFeesDsbrsChrtblAmt>
        <AccountingFeesRevAndExpnssAmt referenceDocumentId="RetDoc2002200001">39679</AccountingFeesRevAndExpnssAmt>
        <AccountingFeesNetInvstIncmAmt>9920</AccountingFeesNetInvstIncmAmt>
        <AccountingFeesChrtblPrpsAmt>29759</AccountingFeesChrtblPrpsAmt>
        <TaxesRevAndExpnssAmt referenceDocumentId="RetDoc2002500001">70000</TaxesRevAndExpnssAmt>
        <TaxesNetInvstIncmAmt>0</TaxesNetInvstIncmAmt>
        <TaxesDsbrsChrtblAmt>0</TaxesDsbrsChrtblAmt>
        <OccupancyRevAndExpnssAmt>1817</OccupancyRevAndExpnssAmt>
        <OccupancyNetInvstIncmAmt>0</OccupancyNetInvstIncmAmt>
        <OccupancyDsbrsChrtblAmt>1817</OccupancyDsbrsChrtblAmt>
        <TravConfMeetingRevAndExpnssAmt>87325</TravConfMeetingRevAndExpnssAmt>
        <TravConfMeetingNetInvstIncmAmt>0</TravConfMeetingNetInvstIncmAmt>
        <TravConfMeetingDsbrsChrtblAmt>87325</TravConfMeetingDsbrsChrtblAmt>
        <OtherExpensesRevAndExpnssAmt referenceDocumentId="RetDoc2003200001">1122920</OtherExpensesRevAndExpnssAmt>
        <OtherExpensesNetInvstIncmAmt>405942</OtherExpensesNetInvstIncmAmt>
        <OtherExpensesDsbrsChrtblAmt>716978</OtherExpensesDsbrsChrtblAmt>
        <TotOprExpensesRevAndExpnssAmt>2508810</TotOprExpensesRevAndExpnssAmt>
        <TotOprExpensesNetInvstIncmAmt>415862</TotOprExpensesNetInvstIncmAmt>
        <TotOprExpensesDsbrsChrtblAmt>2021956</TotOprExpensesDsbrsChrtblAmt>
        <ContriPaidRevAndExpnssAmt>3753149</ContriPaidRevAndExpnssAmt>
        <ContriPaidDsbrsChrtblAmt>3753149</ContriPaidDsbrsChrtblAmt>
        <TotalExpensesRevAndExpnssAmt>6261959</TotalExpensesRevAndExpnssAmt>
        <TotalExpensesNetInvstIncmAmt>415862</TotalExpensesNetInvstIncmAmt>
        <TotalExpensesDsbrsChrtblAmt>5775105</TotalExpensesDsbrsChrtblAmt>
        <ExcessRevenueOverExpensesAmt>8913932</ExcessRevenueOverExpensesAmt>
        <NetInvestmentIncomeAmt>7841633</NetInvestmentIncomeAmt>
      </AnalysisOfRevenueAndExpenses>
      <Form990PFBalanceSheetsGrp>
        <CashBOYAmt>998856</CashBOYAmt>
        <CashEOYAmt>416094</CashEOYAmt>
        <CashEOYFMVAmt>416094</CashEOYFMVAmt>
        <SavAndTempCashInvstBOYAmt>4889756</SavAndTempCashInvstBOYAmt>
        <SavAndTempCashInvstEOYAmt>3726664</SavAndTempCashInvstEOYAmt>
        <SavAndTempCashInvstEOYFMVAmt>3726664</SavAndTempCashInvstEOYFMVAmt>
        <CorporateStockBOYAmt>37569365</CorporateStockBOYAmt>
        <CorporateStockEOYAmt referenceDocumentId="RetDoc2018900001">67836091</CorporateStockEOYAmt>
        <CorporateStockEOYFMVAmt>67836091</CorporateStockEOYFMVAmt>
        <OtherAssetsBOYAmt referenceDocumentId="RetDoc2046600001">9021440</OtherAssetsBOYAmt>
        <OtherAssetsEOYAmt referenceDocumentId="RetDoc2046600001">5909135</OtherAssetsEOYAmt>
        <OtherAssetsEOYFMVAmt referenceDocumentId="RetDoc2046600001">5909135</OtherAssetsEOYFMVAmt>
        <TotalAssetsBOYAmt>52479417</TotalAssetsBOYAmt>
        <TotalAssetsEOYAmt>77887984</TotalAssetsEOYAmt>
        <TotalAssetsEOYFMVAmt>77887984</TotalAssetsEOYFMVAmt>
        <TotalLiabilitiesBOYAmt>0</TotalLiabilitiesBOYAmt>
        <TotalLiabilitiesEOYAmt>0</TotalLiabilitiesEOYAmt>
        <OrgDoesNotFollowFASB117Ind>X</OrgDoesNotFollowFASB117Ind>
        <CapitalStockBOYAmt>0</CapitalStockBOYAmt>
        <CapitalStockEOYAmt>0</CapitalStockEOYAmt>
        <AdditionalPaidInCapitalBOYAmt>0</AdditionalPaidInCapitalBOYAmt>
        <AdditionalPaidInCapitalEOYAmt>0</AdditionalPaidInCapitalEOYAmt>
        <RetainedEarningBOYAmt>52479417</RetainedEarningBOYAmt>
        <RetainedEarningEOYAmt>77887984</RetainedEarningEOYAmt>
        <TotNetAstOrFundBalancesBOYAmt>52479417</TotNetAstOrFundBalancesBOYAmt>
        <TotNetAstOrFundBalancesEOYAmt>77887984</TotNetAstOrFundBalancesEOYAmt>
        <TotalLiabilitiesNetAstBOYAmt>52479417</TotalLiabilitiesNetAstBOYAmt>
        <TotalLiabilitiesNetAstEOYAmt>77887984</TotalLiabilitiesNetAstEOYAmt>
      </Form990PFBalanceSheetsGrp>
      <ChgInNetAssetsFundBalancesGrp>
        <TotNetAstOrFundBalancesBOYAmt>52479417</TotNetAstOrFundBalancesBOYAmt>
        <ExcessRevenueOverExpensesAmt>8913932</ExcessRevenueOverExpensesAmt>
        <OtherIncreasesAmt referenceDocumentId="RetDoc2049700001">16494635</OtherIncreasesAmt>
        <SubtotalAmt>77887984</SubtotalAmt>
        <OtherDecreasesAmt>0</OtherDecreasesAmt>
        <TotNetAstOrFundBalancesEOYAmt>77887984</TotNetAstOrFundBalancesEOYAmt>
      </ChgInNetAssetsFundBalancesGrp>
      <CapGainsLossTxInvstIncmDetail>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>SECURITIES</PropertyDesc>
          <HowAcquiredCd>D</HowAcquiredCd>
          <AcquiredDt>2022-01-01</AcquiredDt>
          <SoldDt>2023-12-31</SoldDt>
          <GrossSalesPriceAmt>8694736</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>1835089</CostOrOtherBasisAmt>
          <GainOrLossAmt>6859647</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>6859647</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>THE CHILDRENS INVESTMENT FUND</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2022-01-01</AcquiredDt>
          <SoldDt>2023-12-31</SoldDt>
          <GrossSalesPriceAmt>1535200</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>1000000</CostOrOtherBasisAmt>
          <GainOrLossAmt>535200</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>535200</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>THRU K1S</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2023-01-01</AcquiredDt>
          <SoldDt>2023-12-31</SoldDt>
          <GainOrLossAmt>1766</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>1766</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapitalGainNetIncomeAmt>7396613</CapitalGainNetIncomeAmt>
      </CapGainsLossTxInvstIncmDetail>
      <ExciseTaxBasedOnInvstIncmGrp>
        <InvestmentIncomeExciseTaxAmt>108999</InvestmentIncomeExciseTaxAmt>
        <TaxUnderSection511Amt>0</TaxUnderSection511Amt>
        <SubtotalAmt>108999</SubtotalAmt>
        <SubtitleATaxAmt>0</SubtitleATaxAmt>
        <TaxBasedOnInvestmentIncomeAmt>108999</TaxBasedOnInvestmentIncomeAmt>
        <EstimatedPlusOvpmtIncmTxAmt>121334</EstimatedPlusOvpmtIncmTxAmt>
        <ExemptFrgnOrgTaxWthldAtSrceAmt>0</ExemptFrgnOrgTaxWthldAtSrceAmt>
        <ExtsnRequestIncomeTaxPaidAmt>65000</ExtsnRequestIncomeTaxPaidAmt>
        <BackupWithholdingWithheldAmt>0</BackupWithholdingWithheldAmt>
        <TotalPaymentsAndCreditsAmt>186334</TotalPaymentsAndCreditsAmt>
        <Form2220AttachedInd referenceDocumentId="RetDoc1192000001">X</Form2220AttachedInd>
        <EsPenaltyAmt>0</EsPenaltyAmt>
        <OverpaymentAmt>77335</OverpaymentAmt>
        <AppliedToESTaxAmt>77335</AppliedToESTaxAmt>
        <RefundAmt>0</RefundAmt>
      </ExciseTaxBasedOnInvstIncmGrp>
      <StatementsRegardingActyGrp>
        <LegislativePoliticalActyInd>0</LegislativePoliticalActyInd>
        <MoreThan100SpentInd>0</MoreThan100SpentInd>
        <Form1120POLFiledInd>0</Form1120POLFiledInd>
        <Section4955OrganizationTaxAmt>0</Section4955OrganizationTaxAmt>
        <Section4955ManagersTaxAmt>0</Section4955ManagersTaxAmt>
        <TaxReimbursedAmt>0</TaxReimbursedAmt>
        <ActivitiesNotPreviouslyRptInd>0</ActivitiesNotPreviouslyRptInd>
        <ChangesToArticlesOrBylawsInd>0</ChangesToArticlesOrBylawsInd>
        <UnrelatedBusIncmOverLimitInd>1</UnrelatedBusIncmOverLimitInd>
        <Form990TFiledInd>1</Form990TFiledInd>
        <OrganizationDissolvedEtcInd>0</OrganizationDissolvedEtcInd>
        <Section508eRqrSatisfiedInd>1</Section508eRqrSatisfiedInd>
        <AtLeast5000InAssetsInd>1</AtLeast5000InAssetsInd>
        <OrgReportOrRegisterStateCd>CT</OrgReportOrRegisterStateCd>
        <Form990PFFiledWithAttyGenInd>1</Form990PFFiledWithAttyGenInd>
        <PrivateOperatingFoundationInd>0</PrivateOperatingFoundationInd>
        <NewSubstantialContributorsInd referenceDocumentId="RetDoc2089200001">1</NewSubstantialContributorsInd>
        <OwnControlledEntityInd>0</OwnControlledEntityInd>
        <DonorAdvisedFundInd>0</DonorAdvisedFundInd>
        <ComplyWithPublicInspRqrInd>1</ComplyWithPublicInspRqrInd>
        <WebsiteAddressTxt>WWW.LIPEDEMA.ORG</WebsiteAddressTxt>
        <IndividualWithBooksNm>PINE RIDGE ADVISERS LLC</IndividualWithBooksNm>
        <PhoneNum>2122730462</PhoneNum>
        <LocationOfBooksUSAddress>
          <AddressLine1Txt>450 LEXINGTON AVE 38TH FL</AddressLine1Txt>
          <CityNm>NEW YORK</CityNm>
          <StateAbbreviationCd>NY</StateAbbreviationCd>
          <ZIPCd>10017</ZIPCd>
        </LocationOfBooksUSAddress>
        <ForeignAccountsQuestionInd>0</ForeignAccountsQuestionInd>
      </StatementsRegardingActyGrp>
      <StatementsRegardingActy4720Grp>
        <SaleOrExchDisqualifiedPrsnInd>0</SaleOrExchDisqualifiedPrsnInd>
        <BrrwOrLendDisqualifiedPrsnInd>0</BrrwOrLendDisqualifiedPrsnInd>
        <FurnGoodsDisqualifiedPrsnInd>0</FurnGoodsDisqualifiedPrsnInd>
        <PayCompDisqualifiedPrsnInd>1</PayCompDisqualifiedPrsnInd>
        <TransferAstDisqualifiedPrsnInd>0</TransferAstDisqualifiedPrsnInd>
        <PaymentToGovernmentOfficialInd>0</PaymentToGovernmentOfficialInd>
        <ActsFailToQlfyAsExceptionsInd>0</ActsFailToQlfyAsExceptionsInd>
        <UncorrectedPriorActsInd>0</UncorrectedPriorActsInd>
        <UndistributedIncomePYInd>0</UndistributedIncomePYInd>
        <BusinessHoldingsInd>0</BusinessHoldingsInd>
        <JeopardyInvestmentsInd>0</JeopardyInvestmentsInd>
        <UncorrectedPYJeopardyInvstInd>0</UncorrectedPYJeopardyInvstInd>
        <InfluenceLegislationInd>0</InfluenceLegislationInd>
        <InfluenceElectionInd>0</InfluenceElectionInd>
        <GrantsToIndividualsInd>0</GrantsToIndividualsInd>
        <GrantsToOrganizationsInd>1</GrantsToOrganizationsInd>
        <NoncharitablePurposeInd>0</NoncharitablePurposeInd>
        <TransactionsFailToQlfyAsExcInd>0</TransactionsFailToQlfyAsExcInd>
        <MaintainedExpenditureRspnsInd referenceDocumentId="RetDoc2118100001">1</MaintainedExpenditureRspnsInd>
        <RcvFndsToPayPrsnlBnftCntrctInd>0</RcvFndsToPayPrsnlBnftCntrctInd>
        <PayPremiumsPrsnlBnftCntrctInd>0</PayPremiumsPrsnlBnftCntrctInd>
        <ProhibitedTaxShelterTransInd>0</ProhibitedTaxShelterTransInd>
        <SubjToTaxRmnrtnExPrchtPymtInd>0</SubjToTaxRmnrtnExPrchtPymtInd>
      </StatementsRegardingActy4720Grp>
      <OfficerDirTrstKeyEmplInfoGrp>
        <OfficerDirTrstKeyEmplGrp>
          <PersonNm>SUHAS DAFTUAR</PersonNm>
          <USAddress>
            <AddressLine1Txt>450 LEXINGTON AVE 38TH FL C/O PINE</AddressLine1Txt>
            <AddressLine2Txt>RIDGE ADVISERS LLC</AddressLine2Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10017</ZIPCd>
          </USAddress>
          <TitleTxt>TRUSTEE</TitleTxt>
          <AverageHrsPerWkDevotedToPosRt>1.00</AverageHrsPerWkDevotedToPosRt>
          <CompensationAmt>0</CompensationAmt>
          <EmployeeBenefitProgramAmt>0</EmployeeBenefitProgramAmt>
          <ExpenseAccountOtherAllwncAmt>0</ExpenseAccountOtherAllwncAmt>
        </OfficerDirTrstKeyEmplGrp>
        <OfficerDirTrstKeyEmplGrp>
          <PersonNm>FELICITIE DAFTUAR</PersonNm>
          <USAddress>
            <AddressLine1Txt>450 LEXINGTON AVE 38TH FL C/O PINE</AddressLine1Txt>
            <AddressLine2Txt>RIDGE ADVISERS LLC</AddressLine2Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10017</ZIPCd>
          </USAddress>
          <TitleTxt>TRUSTEE</TitleTxt>
          <AverageHrsPerWkDevotedToPosRt>1.00</AverageHrsPerWkDevotedToPosRt>
          <CompensationAmt>0</CompensationAmt>
          <EmployeeBenefitProgramAmt>0</EmployeeBenefitProgramAmt>
          <ExpenseAccountOtherAllwncAmt>0</ExpenseAccountOtherAllwncAmt>
        </OfficerDirTrstKeyEmplGrp>
        <OfficerDirTrstKeyEmplGrp>
          <PersonNm>JONATHAN KARTT</PersonNm>
          <USAddress>
            <AddressLine1Txt>39 LEWIS STREET 4TH FL</AddressLine1Txt>
            <CityNm>GREENWICH</CityNm>
            <StateAbbreviationCd>CT</StateAbbreviationCd>
            <ZIPCd>06830</ZIPCd>
          </USAddress>
          <TitleTxt>CEO</TitleTxt>
          <AverageHrsPerWkDevotedToPosRt>40.00</AverageHrsPerWkDevotedToPosRt>
          <CompensationAmt>332770</CompensationAmt>
          <EmployeeBenefitProgramAmt>58115</EmployeeBenefitProgramAmt>
          <ExpenseAccountOtherAllwncAmt>0</ExpenseAccountOtherAllwncAmt>
        </OfficerDirTrstKeyEmplGrp>
        <OfficerDirTrstKeyEmplGrp>
          <PersonNm>BALDO FODERA</PersonNm>
          <USAddress>
            <AddressLine1Txt>450 LEXINGTON AVE 38TH FL C/O PINE</AddressLine1Txt>
            <AddressLine2Txt>RIDGE ADVISERS LLC</AddressLine2Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10017</ZIPCd>
          </USAddress>
          <TitleTxt>MANAGER</TitleTxt>
          <AverageHrsPerWkDevotedToPosRt>1.00</AverageHrsPerWkDevotedToPosRt>
          <CompensationAmt>0</CompensationAmt>
          <EmployeeBenefitProgramAmt>0</EmployeeBenefitProgramAmt>
          <ExpenseAccountOtherAllwncAmt>0</ExpenseAccountOtherAllwncAmt>
        </OfficerDirTrstKeyEmplGrp>
        <CompensationHighestPaidEmplGrp>
          <PersonNm>STEPHANIE GALIA</PersonNm>
          <USAddress>
            <AddressLine1Txt>39 LEWIS STREET 4TH FLOOR</AddressLine1Txt>
            <CityNm>GREENWICH</CityNm>
            <StateAbbreviationCd>CT</StateAbbreviationCd>
            <ZIPCd>06830</ZIPCd>
          </USAddress>
          <TitleTxt>ASSOC. DIRECTOR - SP</TitleTxt>
          <AverageHrsPerWkDevotedToPosRt>40.00</AverageHrsPerWkDevotedToPosRt>
          <CompensationAmt>104400</CompensationAmt>
          <EmployeeBenefitsAmt>48399</EmployeeBenefitsAmt>
          <ExpenseAccountAmt>0</ExpenseAccountAmt>
        </CompensationHighestPaidEmplGrp>
        <CompensationHighestPaidEmplGrp>
          <PersonNm>STEPHANIE PETERSON</PersonNm>
          <USAddress>
            <AddressLine1Txt>39 LEWIS STREET 4TH FLOOR</AddressLine1Txt>
            <CityNm>GREENWICH</CityNm>
            <StateAbbreviationCd>CT</StateAbbreviationCd>
            <ZIPCd>06830</ZIPCd>
          </USAddress>
          <TitleTxt>GRANTS MANAGER</TitleTxt>
          <AverageHrsPerWkDevotedToPosRt>40.00</AverageHrsPerWkDevotedToPosRt>
          <CompensationAmt>122800</CompensationAmt>
          <EmployeeBenefitsAmt>4912</EmployeeBenefitsAmt>
          <ExpenseAccountAmt>0</ExpenseAccountAmt>
        </CompensationHighestPaidEmplGrp>
        <CompensationHighestPaidEmplGrp>
          <PersonNm>JAIME LYNN SODERBERG</PersonNm>
          <USAddress>
            <AddressLine1Txt>39 LEWIS STREET 4TH FLOOR</AddressLine1Txt>
            <CityNm>GREENWICH</CityNm>
            <StateAbbreviationCd>CT</StateAbbreviationCd>
            <ZIPCd>06830</ZIPCd>
          </USAddress>
          <TitleTxt>OFFICE MANAGER</TitleTxt>
          <AverageHrsPerWkDevotedToPosRt>40.00</AverageHrsPerWkDevotedToPosRt>
          <CompensationAmt>103345</CompensationAmt>
          <EmployeeBenefitsAmt>5109</EmployeeBenefitsAmt>
          <ExpenseAccountAmt>0</ExpenseAccountAmt>
        </CompensationHighestPaidEmplGrp>
        <CompensationHighestPaidEmplGrp>
          <PersonNm>GUY EAKIN</PersonNm>
          <USAddress>
            <AddressLine1Txt>39 LEWIS STREET 4TH FLOOR</AddressLine1Txt>
            <CityNm>GREENWICH</CityNm>
            <StateAbbreviationCd>CT</StateAbbreviationCd>
            <ZIPCd>06830</ZIPCd>
          </USAddress>
          <TitleTxt>CHIEF SCIENCE OFFICE</TitleTxt>
          <AverageHrsPerWkDevotedToPosRt>40.00</AverageHrsPerWkDevotedToPosRt>
          <CompensationAmt>93525</CompensationAmt>
          <EmployeeBenefitsAmt>4122</EmployeeBenefitsAmt>
          <ExpenseAccountAmt>0</ExpenseAccountAmt>
        </CompensationHighestPaidEmplGrp>
        <CompensationHighestPaidEmplGrp>
          <PersonNm>LAURA HARMACEK</PersonNm>
          <USAddress>
            <AddressLine1Txt>39 LEWIS STREET 4TH FLOOR</AddressLine1Txt>
            <CityNm>GREENWICH</CityNm>
            <StateAbbreviationCd>CT</StateAbbreviationCd>
            <ZIPCd>06830</ZIPCd>
          </USAddress>
          <TitleTxt>PROGRAM OFFICER</TitleTxt>
          <AverageHrsPerWkDevotedToPosRt>40.00</AverageHrsPerWkDevotedToPosRt>
          <CompensationAmt>83100</CompensationAmt>
          <EmployeeBenefitsAmt>3540</EmployeeBenefitsAmt>
          <ExpenseAccountAmt>0</ExpenseAccountAmt>
        </CompensationHighestPaidEmplGrp>
        <OtherEmployeePaidOver50kCnt>0</OtherEmployeePaidOver50kCnt>
        <CompensationOfHghstPdCntrctGrp>
          <BusinessName>
            <BusinessNameLine1Txt>PINE RIDGE ADVISERS LLC</BusinessNameLine1Txt>
          </BusinessName>
          <USAddress>
            <AddressLine1Txt>450 LEXINGTON AVE 38TH FL</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10017</ZIPCd>
          </USAddress>
          <ServiceTypeTxt>ADVISORY SERVICES</ServiceTypeTxt>
          <CompensationAmt>371994</CompensationAmt>
        </CompensationOfHghstPdCntrctGrp>
        <CompensationOfHghstPdCntrctGrp>
          <BusinessName>
            <BusinessNameLine1Txt>GEBEN COMMUNICATIONS</BusinessNameLine1Txt>
          </BusinessName>
          <USAddress>
            <AddressLine1Txt>143 E MAIN ST 200</AddressLine1Txt>
            <CityNm>COLUMBUS</CityNm>
            <StateAbbreviationCd>OH</StateAbbreviationCd>
            <ZIPCd>43215</ZIPCd>
          </USAddress>
          <ServiceTypeTxt>MARKETING SERVICE</ServiceTypeTxt>
          <CompensationAmt>77250</CompensationAmt>
        </CompensationOfHghstPdCntrctGrp>
        <CompensationOfHghstPdCntrctGrp>
          <BusinessName>
            <BusinessNameLine1Txt>SANDLER SEARCH</BusinessNameLine1Txt>
          </BusinessName>
          <USAddress>
            <AddressLine1Txt>485 MADISON AVE</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10022</ZIPCd>
          </USAddress>
          <ServiceTypeTxt>RECRUITING SERVICE</ServiceTypeTxt>
          <CompensationAmt>68403</CompensationAmt>
        </CompensationOfHghstPdCntrctGrp>
        <CompensationOfHghstPdCntrctGrp>
          <BusinessName>
            <BusinessNameLine1Txt>INTERLACED LLC</BusinessNameLine1Txt>
          </BusinessName>
          <USAddress>
            <AddressLine1Txt>1660 LOGAN AVE SUITE A</AddressLine1Txt>
            <CityNm>SAN DIEGO</CityNm>
            <StateAbbreviationCd>CA</StateAbbreviationCd>
            <ZIPCd>92113</ZIPCd>
          </USAddress>
          <ServiceTypeTxt>IT SERVICE</ServiceTypeTxt>
          <CompensationAmt>55025</CompensationAmt>
        </CompensationOfHghstPdCntrctGrp>
        <ContractorPaidOver50kCnt>0</ContractorPaidOver50kCnt>
      </OfficerDirTrstKeyEmplInfoGrp>
      <SumOfProgramRelatedInvstGrp>
        <TotalAmt>0</TotalAmt>
      </SumOfProgramRelatedInvstGrp>
      <MinimumInvestmentReturnGrp>
        <AverageMonthlyFMVOfSecAmt>50275071</AverageMonthlyFMVOfSecAmt>
        <AverageMonthlyCashBalancesAmt>4342889</AverageMonthlyCashBalancesAmt>
        <FMVAllOtherNoncharitableAstAmt>5674430</FMVAllOtherNoncharitableAstAmt>
        <TotalFMVOfUnusedAssetsAmt>60292390</TotalFMVOfUnusedAssetsAmt>
        <ReductionClaimedAmt>0</ReductionClaimedAmt>
        <AcquisitionIndebtednessAmt>0</AcquisitionIndebtednessAmt>
        <AdjustedTotalFMVOfUnusedAstAmt>60292390</AdjustedTotalFMVOfUnusedAstAmt>
        <CashDeemedCharitableAmt>904386</CashDeemedCharitableAmt>
        <NetVlNoncharitableAssetsAmt>59388004</NetVlNoncharitableAssetsAmt>
        <MinimumInvestmentReturnAmt>2969400</MinimumInvestmentReturnAmt>
      </MinimumInvestmentReturnGrp>
      <DistributableAmountGrp>
        <MinimumInvestmentReturnAmt>2969400</MinimumInvestmentReturnAmt>
        <TaxBasedOnInvestmentIncomeAmt>108999</TaxBasedOnInvestmentIncomeAmt>
        <IncomeTaxAmt>261</IncomeTaxAmt>
        <TotalTaxAmt>109260</TotalTaxAmt>
        <DistributableBeforeAdjAmt>2860140</DistributableBeforeAdjAmt>
        <RecoveriesQualfiedDistriAmt>389</RecoveriesQualfiedDistriAmt>
        <DistributableBeforeDedAmt>2860529</DistributableBeforeDedAmt>
        <DeductionFromDistributableAmt>0</DeductionFromDistributableAmt>
        <DistributableAsAdjustedAmt>2860529</DistributableAsAdjustedAmt>
      </DistributableAmountGrp>
      <PFQualifyingDistributionsGrp>
        <ExpensesAndContributionsAmt>5775105</ExpensesAndContributionsAmt>
        <ProgramRelatedInvstTotalAmt>0</ProgramRelatedInvstTotalAmt>
        <QualifyingDistributionsAmt>5775105</QualifyingDistributionsAmt>
      </PFQualifyingDistributionsGrp>
      <UndistributedIncomeGrp>
        <DistributableAsAdjustedAmt>2860529</DistributableAsAdjustedAmt>
        <UndistributedIncomePYAmt>0</UndistributedIncomePYAmt>
        <TotalForPriorYearsAmt>0</TotalForPriorYearsAmt>
        <ExcessDistributionCyovYr5Amt>121184</ExcessDistributionCyovYr5Amt>
        <ExcessDistributionCyovYr4Amt>1499044</ExcessDistributionCyovYr4Amt>
        <ExcessDistributionCyovYr2Amt>1403569</ExcessDistributionCyovYr2Amt>
        <ExcessDistributionCyovYr1Amt>350059</ExcessDistributionCyovYr1Amt>
        <TotalExcessDistributionCyovAmt>3373856</TotalExcessDistributionCyovAmt>
        <QualifyingDistributionsAmt>5775105</QualifyingDistributionsAmt>
        <AppliedToYear1Amt>0</AppliedToYear1Amt>
        <AppliedToPriorYearsAmt>0</AppliedToPriorYearsAmt>
        <TreatedAsDistriFromCorpusAmt>0</TreatedAsDistriFromCorpusAmt>
        <AppliedToCurrentYearAmt>2860529</AppliedToCurrentYearAmt>
        <RemainingDistriFromCorpusAmt>2914576</RemainingDistriFromCorpusAmt>
        <ExcessDistriCyovAppCYCorpusAmt>0</ExcessDistriCyovAppCYCorpusAmt>
        <ExcessDistributionCyovAppCYAmt>0</ExcessDistributionCyovAppCYAmt>
        <TotalCorpusAmt>6288432</TotalCorpusAmt>
        <PriorYearUndistributedIncmAmt>0</PriorYearUndistributedIncmAmt>
        <PriorYearDeficiencyOrTaxAmt>0</PriorYearDeficiencyOrTaxAmt>
        <Taxable1Amt>0</Taxable1Amt>
        <Taxable2Amt>0</Taxable2Amt>
        <UndistributedIncomeCYAmt>0</UndistributedIncomeCYAmt>
        <CorpusDistri170b1EOr4942g3Amt>0</CorpusDistri170b1EOr4942g3Amt>
        <ExcessDistriCyovFromYr5Amt>121184</ExcessDistriCyovFromYr5Amt>
        <ExcessDistriCyovToNextYrAmt>6167248</ExcessDistriCyovToNextYrAmt>
        <ExcessFromYear4Amt>1499044</ExcessFromYear4Amt>
        <ExcessFromYear2Amt>1403569</ExcessFromYear2Amt>
        <ExcessFromYear1Amt>350059</ExcessFromYear1Amt>
        <ExcessFromCurrentYearAmt>2914576</ExcessFromCurrentYearAmt>
      </UndistributedIncomeGrp>
      <SupplementaryInformationGrp>
        <ContributingManagerNm>SUHAS DAFTUAR</ContributingManagerNm>
        <ContributingManagerNm>FELICITIE DAFTUAR</ContributingManagerNm>
        <ContributingManagerNm>BALDO FODERA</ContributingManagerNm>
        <ApplicationSubmissionInfoGrp>
          <RecipientPersonNm>FELICITIE DAFTUAR</RecipientPersonNm>
          <RecipientUSAddress>
            <AddressLine1Txt>C/O PINE RIDGE 450 LEXINGTON AVE</AddressLine1Txt>
            <AddressLine2Txt>38TH FL</AddressLine2Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10017</ZIPCd>
          </RecipientUSAddress>
          <RecipientPhoneNum>2034892989</RecipientPhoneNum>
          <RecipientEmailAddressTxt>INFO@LIPEDEMA.ORG</RecipientEmailAddressTxt>
          <FormAndInfoAndMaterialsTxt>PLEASE REFER TO THE FOUNDATION WEBSITE FOR ADDITIONAL INFORMATION REGARDING GRANT APPLICATIONS - WWW.LIPEDEMA.ORG</FormAndInfoAndMaterialsTxt>
          <SubmissionDeadlinesTxt>PLEASE REFER TO FOUNDATION WEBSITE FOR INFORMATION REGARDING SUBMISSION DEADLINES -WWW.LIPEDEMA.ORG</SubmissionDeadlinesTxt>
          <RestrictionsOnAwardsTxt>PLEASE REFER TO THE FOUNDATION WEBSITE FOR ADDITIONAL INFORMATION REGARDING RESTRICTIONS OR LIMITATIONS ON AWARDS - WWW.LIPEDEMA.ORG</RestrictionsOnAwardsTxt>
        </ApplicationSubmissionInfoGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>GREENWICH ACADEMY INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>200 NORTH MAPLE AVENUE</AddressLine1Txt>
            <CityNm>GREENWICH</CityNm>
            <StateAbbreviationCd>CT</StateAbbreviationCd>
            <ZIPCd>06830</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NONE</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>CENTER FOR MATH EXCELLENCE AS PART OF LEAD THE WAY CAMPAIGN</GrantOrContributionPurposeTxt>
          <Amt>500000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>GREENWICH ACADEMY INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>200 NORTH MAPLE AVENUE</AddressLine1Txt>
            <CityNm>GREENWICH</CityNm>
            <StateAbbreviationCd>CT</StateAbbreviationCd>
            <ZIPCd>06830</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NONE</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>CENTER FOR MATH EXCELLENCE AS PART OF LEAD THE WAY CAMPAIGN</GrantOrContributionPurposeTxt>
          <Amt>600000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>KLINIKUM ERNST VON BERGMANN GEMEINNUTZIGE GMBH</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>CHARLOTTENSTRABE 72</AddressLine1Txt>
            <CityNm>POTTSDAM</CityNm>
            <CountryCd>GM</CountryCd>
            <ForeignPostalCd>14467</ForeignPostalCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NONE</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>NC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>RESEARCH PROPOSAL - "MORPHOLOGICAL MRI INVESTIGATION OF SUBCUTANEOUS ADIPOSE TISSUE IN LIPEDEMA PATIENTS"</GrantOrContributionPurposeTxt>
          <Amt>148186</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>LYSEARCH GMBH</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>BIBESTR 7</AddressLine1Txt>
            <CityNm>COLOGNE</CityNm>
            <CountryCd>GM</CountryCd>
            <ForeignPostalCd>50678</ForeignPostalCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NONE</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>NC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>RESEARCH PROPOSAL - "HOW DOES BARIATRIC SURGERY AFFECT LIPEDEMA"</GrantOrContributionPurposeTxt>
          <Amt>56201</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>MACQUARIE UNIVERSITY</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>75 TALAVERA RD LEVEL 1</AddressLine1Txt>
            <CityNm>SYDNEY</CityNm>
            <CountryCd>AS</CountryCd>
            <ForeignPostalCd>2019</ForeignPostalCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NONE</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>NC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>RESEARCH PROPOSAL - "UTILIZING INDOCYANINE GREEN LYMPHOGRAPHY (ICG) AND BIOIMPEDANCE"</GrantOrContributionPurposeTxt>
          <Amt>127802</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>PRESIDENT AND FELLOWS OF HARVARD COLLEGE</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>124 MOUNT AUBURN STREET</AddressLine1Txt>
            <CityNm>CAMBRIDGE</CityNm>
            <StateAbbreviationCd>MA</StateAbbreviationCd>
            <ZIPCd>02138</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NONE</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EMBEDDED ETHICS FUND AND QUANTUM INITIATIVE FUND</GrantOrContributionPurposeTxt>
          <Amt>833334</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>ST GEORGE'S UNIVERSITY LONDON</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>CRAMER TERRACE</AddressLine1Txt>
            <CityNm>LONDON</CityNm>
            <CountryCd>UK</CountryCd>
            <ForeignPostalCd>SW17 0RE</ForeignPostalCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NONE</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>NC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>RESEARCH PROPOSAL - "DECIPHERING THE GENETIC BASIS OF LIPEDEMA"</GrantOrContributionPurposeTxt>
          <Amt>69597</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>ST VINCENT'S INSTITUTE FOR MEDICAL RESEARCH</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>9 PRINCES STREET</AddressLine1Txt>
            <CityNm>FITZROY</CityNm>
            <CountryCd>AS</CountryCd>
            <ForeignPostalCd>3065</ForeignPostalCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NONE</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>NC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>RESEARCH PROPOSAL - "INVESTIGATING A FUNCTIONALLY IMPORTANT POPULATION OF IMMUNE CELLS AS ABIOMARKER AND POTENTIAL THERAPEUTIC TARGET IN LIPEDEMA"</GrantOrContributionPurposeTxt>
          <Amt>54070</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>TEMPLE UNIVERSITY - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1803 N BROAD ST CARNELL HALL SUITE</AddressLine1Txt>
            <AddressLine2Txt>618</AddressLine2Txt>
            <CityNm>PHILADELPHIA</CityNm>
            <StateAbbreviationCd>PA</StateAbbreviationCd>
            <ZIPCd>19122</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NONE</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>RESEARCH PROPOSAL - "CHARACTERIZATION OF BIOTRANSPORT THROUGH ENGINEERED LIPEDEMIC TISSUES"</GrantOrContributionPurposeTxt>
          <Amt>125742</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE CLEVELAND CLINIC FOUNDATION</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>9500 EUCLID AVENUE</AddressLine1Txt>
            <CityNm>CLEVELAND</CityNm>
            <StateAbbreviationCd>OH</StateAbbreviationCd>
            <ZIPCd>44195</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NONE</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>RESEARCH PROPOSAL - "PLATELETS AS BIOSENSORS AND REGULATORS OF METABOLISM IN LIPEDEMA"</GrantOrContributionPurposeTxt>
          <Amt>59345</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE REGENTS OF THE UNIVERSITY OF CALIFORNIA LOS ANGELES</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>615 CHARLES E YOUNG DRIVE SOUTH</AddressLine1Txt>
            <CityNm>LOS ANGELES</CityNm>
            <StateAbbreviationCd>CA</StateAbbreviationCd>
            <ZIPCd>90095</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NONE</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>RESEARCH PROPOSAL - "MESENCHYMAL PROGENITOR CELLS IN LIPEDEMA"</GrantOrContributionPurposeTxt>
          <Amt>125000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>UNIVERSITY HOSPITAL COLOGNE</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>JOSEPH-STELTZMANN - STR 9</AddressLine1Txt>
            <CityNm>COLOGNE</CityNm>
            <CountryCd>GM</CountryCd>
            <ForeignPostalCd>50931</ForeignPostalCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NONE</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>NC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>RESEARCH PROPOSAL - "IDENTIFICATION OF LIPEDEMA-PAIN SPECIFIC SENSORY MEASURES AS BASIS FORFUTURE DIAGNOSTICS"</GrantOrContributionPurposeTxt>
          <Amt>21412</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>UNIVERSITY OF LEIPZIG</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>PHILLIPP-ROSENTHAL STR 27</AddressLine1Txt>
            <CityNm>LEIPZIG</CityNm>
            <CountryCd>GM</CountryCd>
            <ForeignPostalCd>04103</ForeignPostalCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NONE</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>NC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>RESEARCH PROPOSAL - "MECHANISMS UNDERLYING THE DEVELOPMENT AND CLINICAL MANIFESTATIONS OF LIPEDEMA"</GrantOrContributionPurposeTxt>
          <Amt>136416</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>3500 CAMP BOWIE</AddressLine1Txt>
            <CityNm>FORT WORTH</CityNm>
            <StateAbbreviationCd>TX</StateAbbreviationCd>
            <ZIPCd>76107</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NONE</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>RESEARCH PROPOSAL - "ESTROGEN SIGNALING IN ADIPOSE TISSUE METABOLISM AND DEVELOPMENT OF LIPEDEMA"</GrantOrContributionPurposeTxt>
          <Amt>123750</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>UNIVERSITY OF PADOVA</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>VIA GIUSTINIIANI N 2</AddressLine1Txt>
            <CityNm>PADOVA</CityNm>
            <CountryCd>IT</CountryCd>
            <ForeignPostalCd>35128</ForeignPostalCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NONE</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>NC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>RESEARCH PROPOSAL - "ROLE OF FASCIAL ALTERATIONS IN LIPEDEMA"</GrantOrContributionPurposeTxt>
          <Amt>140346</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>UNIVERSITY OF THE PACIFIC WEB DEPOSITORY</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>3601 PACIFIC AVE</AddressLine1Txt>
            <CityNm>STOCKTON</CityNm>
            <StateAbbreviationCd>CA</StateAbbreviationCd>
            <ZIPCd>95211</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NONE</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>RESEARCH PROPOSAL - "TURNING UP THE HEAT ON LIPEDEMA"</GrantOrContributionPurposeTxt>
          <Amt>118137</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>UNIVERSITY OF ZURICH</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>RAMISTRASSE 100 OFFICE AUFN E 11</AddressLine1Txt>
            <CityNm>ZURICH</CityNm>
            <CountryCd>SZ</CountryCd>
            <ForeignPostalCd>CH-8091</ForeignPostalCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NONE</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>NC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>RESEARCH PROPOSAL - "INVESTIGATING THE DIAGNOSTIC AND THERAPEUTIC POTENTIAL OF CD163 BIOMARKER IN LEPEDEMA"</GrantOrContributionPurposeTxt>
          <Amt>159678</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>VANDERBILT UNIVERSITY MEDICAL CENTER</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>3319 WEST END AVENUE SUITE 100</AddressLine1Txt>
            <CityNm>NASHVILLE</CityNm>
            <StateAbbreviationCd>TN</StateAbbreviationCd>
            <ZIPCd>37203</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NONE</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>RESEARCH PROPOSAL - "INVESTIGATION OF BIOLOGICAL SAMPLES AND RELATED DATA ABOUT LIPEDEMA"</GrantOrContributionPurposeTxt>
          <Amt>354133</Amt>
        </GrantOrContributionPdDurYrGrp>
        <TotalGrantOrContriPdDurYrAmt>3753149</TotalGrantOrContriPdDurYrAmt>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>PRESIDENT AND FELLOWS OF HARVARD COLLEGE</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>124 MOUNT AUBURN STREET</AddressLine1Txt>
            <CityNm>CAMBRIDGE</CityNm>
            <StateAbbreviationCd>MA</StateAbbreviationCd>
            <ZIPCd>02138</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NONE</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EMBEDDED ETHICS FUND AND QUANTUM INITIATIVE FUND</GrantOrContributionPurposeTxt>
          <Amt>1666666</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>ST VINCENT'S INSTITUTE FOR MEDICAL RESEARCH</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>9 PRINCES STREET</AddressLine1Txt>
            <CityNm>FITZROY</CityNm>
            <CountryCd>AS</CountryCd>
            <ForeignPostalCd>3065</ForeignPostalCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NONE</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>NC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>RESEARCH PROPOSAL - "INVESTIGATING A FUNCTIONALLY IMPORTANT POPULATION OF IMMUNE CELLS AS ABIOMARKER AND POTENTIAL THERAPEUTIC TARGET IN LIPEDEMA"</GrantOrContributionPurposeTxt>
          <Amt>112890</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>UNIVERSITY HOSPITAL COLOGNE</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>JOSEPH-STELTZMANN - STR 9</AddressLine1Txt>
            <CityNm>COLOGNE</CityNm>
            <CountryCd>GM</CountryCd>
            <ForeignPostalCd>50931</ForeignPostalCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NONE</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>NC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>RESEARCH PROPOSAL - "IDENTIFICATION OF LIPEDEMA-PAIN SPECIFIC SENSORY MEASURES AS BASIS FORFUTURE DIAGNOSTICS"</GrantOrContributionPurposeTxt>
          <Amt>88981</Amt>
        </GrantOrContriApprvForFutGrp>
        <TotalGrantOrContriApprvFutAmt>1868537</TotalGrantOrContriApprvFutAmt>
      </SupplementaryInformationGrp>
      <AnalysisIncomeProducingActyGrp>
        <IntOnSavAndTempCashInvstGrp>
          <ExclusionCd>14</ExclusionCd>
          <ExclusionAmt>34267</ExclusionAmt>
        </IntOnSavAndTempCashInvstGrp>
        <DividendsAndInterestFromSecDtl>
          <ExclusionCd>14</ExclusionCd>
          <ExclusionAmt>845709</ExclusionAmt>
        </DividendsAndInterestFromSecDtl>
        <GainSalesAstOthThanInvntryGrp>
          <ExclusionCd>18</ExclusionCd>
          <ExclusionAmt>-868336</ExclusionAmt>
        </GainSalesAstOthThanInvntryGrp>
        <OtherRevenueDescribedGrp>
          <Desc>OTHER INCOME FROM PARTNERSHIPS</Desc>
          <BusinessCd>523000</BusinessCd>
          <ExclusionCd>14</ExclusionCd>
          <ExclusionAmt>-910</ExclusionAmt>
        </OtherRevenueDescribedGrp>
        <OtherRevenueDescribedGrp>
          <Desc>RECOVERY OF PRIOR YEAR QUALIFYING DISTRIBUTION</Desc>
          <ExclusionCd>14</ExclusionCd>
          <ExclusionAmt>389</ExclusionAmt>
        </OtherRevenueDescribedGrp>
        <SubtotalsIncmProducingActyGrp>
          <UnrelatedBusinessTaxblIncmAmt>0</UnrelatedBusinessTaxblIncmAmt>
          <ExclusionAmt>11119</ExclusionAmt>
          <RelatedOrExemptFunctionIncmAmt>0</RelatedOrExemptFunctionIncmAmt>
        </SubtotalsIncmProducingActyGrp>
        <TotalIncomeProducingActyAmt>11119</TotalIncomeProducingActyAmt>
      </AnalysisIncomeProducingActyGrp>
      <TrnsfrTransRlnNonchrtblEOGrp>
        <TrnsfrOfCashToNonchrtblEOInd>0</TrnsfrOfCashToNonchrtblEOInd>
        <TrnsfrOtherAssetNonchrtblEOInd>0</TrnsfrOtherAssetNonchrtblEOInd>
        <SalesOrExchangesOfAssetsInd>0</SalesOrExchangesOfAssetsInd>
        <PurchaseOfAssetsNonchrtblEOInd>0</PurchaseOfAssetsNonchrtblEOInd>
        <RentalOfFacilitiesOthAssetsInd>0</RentalOfFacilitiesOthAssetsInd>
        <ReimbursementArrangementsInd>0</ReimbursementArrangementsInd>
        <LoansOrLoanGuaranteesInd>0</LoansOrLoanGuaranteesInd>
        <PerformanceOfServicesEtcInd>0</PerformanceOfServicesEtcInd>
        <SharingOfFacilitiesEtcInd>0</SharingOfFacilitiesEtcInd>
        <RelationshipsNonchrtblEOInd>0</RelationshipsNonchrtblEOInd>
      </TrnsfrTransRlnNonchrtblEOGrp>
    </IRS990PF>
    <IRS990ScheduleB documentId="RetDoc1234500001">
      <Organization501c3ExemptPFInd>X</Organization501c3ExemptPFInd>
      <GeneralRuleInd>X</GeneralRuleInd>
      <ContributorInformationGrp>
        <ContributorNum>1</ContributorNum>
        <ContributorPersonNm>SUHAS K FELICITIE J DAFTUAR</ContributorPersonNm>
        <ContributorUSAddress>
          <AddressLine1Txt>450 LEXINGTON AVE 38TH FL</AddressLine1Txt>
          <CityNm>NEW YORK</CityNm>
          <StateAbbreviationCd>NY</StateAbbreviationCd>
          <ZIPCd>10017</ZIPCd>
        </ContributorUSAddress>
        <TotalContributionsAmt>15163672</TotalContributionsAmt>
        <PersonContributionInd>X</PersonContributionInd>
        <NoncashContributionInd>X</NoncashContributionInd>
      </ContributorInformationGrp>
      <NonCashPropertyContributionGrp>
        <ContributorNum>1</ContributorNum>
        <NoncashPropertyDesc>14,800 SHS ALPHABET INC CLASS A (GOOGL)</NoncashPropertyDesc>
        <FairMarketValueAmt>2000072</FairMarketValueAmt>
        <ReceivedDt>2023-11-20</ReceivedDt>
      </NonCashPropertyContributionGrp>
      <NonCashPropertyContributionGrp>
        <ContributorNum>1</ContributorNum>
        <NoncashPropertyDesc>10,600 SHS APPLE INC (APPL)</NoncashPropertyDesc>
        <FairMarketValueAmt>2023487</FairMarketValueAmt>
        <ReceivedDt>2023-11-20</ReceivedDt>
      </NonCashPropertyContributionGrp>
      <NonCashPropertyContributionGrp>
        <ContributorNum>1</ContributorNum>
        <NoncashPropertyDesc>12,000 SHS INTEL CORP (INTC)</NoncashPropertyDesc>
        <FairMarketValueAmt>532260</FairMarketValueAmt>
        <ReceivedDt>2023-11-20</ReceivedDt>
      </NonCashPropertyContributionGrp>
      <NonCashPropertyContributionGrp>
        <ContributorNum>1</ContributorNum>
        <NoncashPropertyDesc>22,300 SHS ALPHABET INC CLASS A (GOOGL)</NoncashPropertyDesc>
        <FairMarketValueAmt>3013622</FairMarketValueAmt>
        <ReceivedDt>2023-11-20</ReceivedDt>
      </NonCashPropertyContributionGrp>
      <NonCashPropertyContributionGrp>
        <ContributorNum>1</ContributorNum>
        <NoncashPropertyDesc>36,700 SHS APPLE INC (APPL)</NoncashPropertyDesc>
        <FairMarketValueAmt>7005847</FairMarketValueAmt>
        <ReceivedDt>2023-11-20</ReceivedDt>
      </NonCashPropertyContributionGrp>
      <NonCashPropertyContributionGrp>
        <ContributorNum>1</ContributorNum>
        <NoncashPropertyDesc>10,368 SHS PAYPAL HOLDINGS INC (PYPL)</NoncashPropertyDesc>
        <FairMarketValueAmt>588384</FairMarketValueAmt>
        <ReceivedDt>2023-11-20</ReceivedDt>
      </NonCashPropertyContributionGrp>
    </IRS990ScheduleB>
    <AccountingFeesSchedule documentId="RetDoc2002200001">
      <AccountingFeesDetail>
        <CategoryTxt>ACCOUNTING AND TAX PREP FEES</CategoryTxt>
        <Amt>39679</Amt>
        <NetInvestmentIncomeAmt>9920</NetInvestmentIncomeAmt>
        <DisbursementsCharitablePrpsAmt>29759</DisbursementsCharitablePrpsAmt>
      </AccountingFeesDetail>
    </AccountingFeesSchedule>
    <ExpenditureResponsibilityStmt documentId="RetDoc2118100001">
      <ExpenditureResponsibilityGrp>
        <BusinessName>
          <BusinessNameLine1Txt>UNIVERSITY OF ZURICH</BusinessNameLine1Txt>
        </BusinessName>
        <ForeignAddress>
          <AddressLine1Txt>RAEMISTRASSE 100</AddressLine1Txt>
          <CityNm>ZURICH</CityNm>
          <CountryCd>SZ</CountryCd>
          <ForeignPostalCd>SW17 ORE</ForeignPostalCd>
        </ForeignAddress>
        <GrantDt>2023-08-10</GrantDt>
        <GrantAmt>159678</GrantAmt>
        <PurposeOfGrantTxt>RESEARCH PROPOSAL - INVESTIGATING THE DIAGNOSTIC AND THERAPEUTIC POTENTIAL OF CD163 BIOMARKER IN LEPEDEMA</PurposeOfGrantTxt>
        <ExpendedByGranteeAmt>159678</ExpendedByGranteeAmt>
        <AnyDiversionByGranteeTxt>NO</AnyDiversionByGranteeTxt>
        <DatesOfReportsByGranteeTxt>10/25/2024</DatesOfReportsByGranteeTxt>
        <ResultsOfVerificationTxt>TO THE KNOWLEDGE OF THE FOUNDATION, THE GRANTEE HAS NOT DIVERTED ANY PORTION OF THE GRANTS FROM THE PURPOSE FOR WHICH THE GRANT WAS MADE.</ResultsOfVerificationTxt>
      </ExpenditureResponsibilityGrp>
      <ExpenditureResponsibilityGrp>
        <BusinessName>
          <BusinessNameLine1Txt>ST GEORGE'S UNIVERSITY OF LONDON</BusinessNameLine1Txt>
        </BusinessName>
        <ForeignAddress>
          <AddressLine1Txt>CRANMER TERRACE</AddressLine1Txt>
          <CityNm>LONDON</CityNm>
          <CountryCd>UK</CountryCd>
          <ForeignPostalCd>SW17 0RE</ForeignPostalCd>
        </ForeignAddress>
        <GrantDt>2023-11-01</GrantDt>
        <GrantAmt>69597</GrantAmt>
        <PurposeOfGrantTxt>RESEARCH PROPOSAL- DECIPHERING THE GENETIC BASIS OF LIPEDEMA</PurposeOfGrantTxt>
        <ExpendedByGranteeAmt>63746</ExpendedByGranteeAmt>
        <AnyDiversionByGranteeTxt>NO</AnyDiversionByGranteeTxt>
        <DatesOfReportsByGranteeTxt>10/21/2024</DatesOfReportsByGranteeTxt>
        <ResultsOfVerificationTxt>TO THE KNOWLEDGE OF THE FOUNDATION, THE GRANTEE HAS NOT DIVERTED ANY PORTION OF THE GRANTS FROM THE PURPOSE FOR WHICH THE GRANT WAS MADE.</ResultsOfVerificationTxt>
      </ExpenditureResponsibilityGrp>
      <ExpenditureResponsibilityGrp>
        <BusinessName>
          <BusinessNameLine1Txt>LYSEARCH GMBH</BusinessNameLine1Txt>
        </BusinessName>
        <ForeignAddress>
          <AddressLine1Txt>BIBESTR 7</AddressLine1Txt>
          <CityNm>COLOGNE</CityNm>
          <CountryCd>GM</CountryCd>
          <ForeignPostalCd>50678 KLN</ForeignPostalCd>
        </ForeignAddress>
        <GrantDt>2021-12-06</GrantDt>
        <GrantAmt>43805</GrantAmt>
        <PurposeOfGrantTxt>RESEARCH PROPOSAL - HOW DOES BARIATRIC SURGERY AFFECT LIPEDEMA</PurposeOfGrantTxt>
        <ExpendedByGranteeAmt>43805</ExpendedByGranteeAmt>
        <AnyDiversionByGranteeTxt>NO</AnyDiversionByGranteeTxt>
        <DatesOfReportsByGranteeTxt>09/01/2024</DatesOfReportsByGranteeTxt>
        <ResultsOfVerificationTxt>TO THE KNOWLEDGE OF THE FOUNDATION, THE GRANTEE HAS NOT DIVERTED ANY PORTION OF THE GRANTS FROM THE PURPOSE FOR WHICH THE GRANT WAS MADE.</ResultsOfVerificationTxt>
      </ExpenditureResponsibilityGrp>
      <ExpenditureResponsibilityGrp>
        <BusinessName>
          <BusinessNameLine1Txt>UNIVERSITE LIBRE DE BRUXELLES</BusinessNameLine1Txt>
        </BusinessName>
        <ForeignAddress>
          <AddressLine1Txt>AV FRANKLIN ROOSEVELT 50</AddressLine1Txt>
          <CityNm>BRUXELLES</CityNm>
          <CountryCd>BE</CountryCd>
          <ForeignPostalCd>1050</ForeignPostalCd>
        </ForeignAddress>
        <GrantDt>2022-09-22</GrantDt>
        <GrantAmt>124921</GrantAmt>
        <PurposeOfGrantTxt>RESEARCH PROPOSAL - BASIC TOOLBOX FOR LIPEDEMA SYNDROME ASSESSMENT</PurposeOfGrantTxt>
        <ExpendedByGranteeAmt>61977</ExpendedByGranteeAmt>
        <AnyDiversionByGranteeTxt>NO</AnyDiversionByGranteeTxt>
        <DatesOfReportsByGranteeTxt>09/01/2024</DatesOfReportsByGranteeTxt>
        <ResultsOfVerificationTxt>TO THE KNOWLEDGE OF THE FOUNDATION, THE GRANTEE HAS NOT DIVERTED ANY PORTION OF THE GRANTS FROM THE PURPOSE FOR WHICH THE GRANT WAS MADE.</ResultsOfVerificationTxt>
      </ExpenditureResponsibilityGrp>
      <ExpenditureResponsibilityGrp>
        <BusinessName>
          <BusinessNameLine1Txt>KLINIKUM ERNST VON BERGMANN GEMEINNUTZIGE GMBH</BusinessNameLine1Txt>
        </BusinessName>
        <ForeignAddress>
          <AddressLine1Txt>CHARLOTTENSTRAE 72</AddressLine1Txt>
          <CityNm>POTSDAM</CityNm>
          <CountryCd>GM</CountryCd>
          <ForeignPostalCd>14467</ForeignPostalCd>
        </ForeignAddress>
        <GrantDt>2022-01-13</GrantDt>
        <GrantAmt>156474</GrantAmt>
        <PurposeOfGrantTxt>RESEARCH PROPOSAL - MORPHOLOGICAL MRI INVESTIGATION OF SUBCUTANEOUS ADIPOSE TISSUE IN LIPEDEMA PATIENTS</PurposeOfGrantTxt>
        <ExpendedByGranteeAmt>38941</ExpendedByGranteeAmt>
        <AnyDiversionByGranteeTxt>NO</AnyDiversionByGranteeTxt>
        <DatesOfReportsByGranteeTxt>2/10/23</DatesOfReportsByGranteeTxt>
        <ResultsOfVerificationTxt>TO THE KNOWLEDGE OF THE FOUNDATION, THE GRANTEE HAS NOT DIVERTED ANY PORTION OF THE GRANTS FROM THE PURPOSE FOR WHICH THE GRANT WAS MADE.</ResultsOfVerificationTxt>
      </ExpenditureResponsibilityGrp>
      <ExpenditureResponsibilityGrp>
        <BusinessName>
          <BusinessNameLine1Txt>UNIVERSITY OF LEIPZIG</BusinessNameLine1Txt>
        </BusinessName>
        <ForeignAddress>
          <AddressLine1Txt>PHILLIPP-ROSENTHAL STR 27</AddressLine1Txt>
          <CityNm>LEIPZIG</CityNm>
          <CountryCd>GM</CountryCd>
          <ForeignPostalCd>04103</ForeignPostalCd>
        </ForeignAddress>
        <GrantDt>2023-10-18</GrantDt>
        <GrantAmt>136416</GrantAmt>
        <PurposeOfGrantTxt>RESEARCH PROPOSAL - MECHANISMS UNDERLYING THE DEVELOPMENT AND CLINICAL MANIFESTATIONS OF LIPEDEMA</PurposeOfGrantTxt>
        <ExpendedByGranteeAmt>0</ExpendedByGranteeAmt>
        <AnyDiversionByGranteeTxt>NO</AnyDiversionByGranteeTxt>
        <ResultsOfVerificationTxt>THE EXPENDITURE RESPONSIBILITY REPORT HAS NOT YET BEEN RECEIVED FROM THE GRANTEE ORGANIZATION AS OF THE DUE DATE OF THE RETURN. TO THE KNOWLEDGE OF THE FOUNDATION, THE GRANTEE HAS NOT DIVERTED ANY PORTION OF THE GRANTS FROM THE PURPOSE FOR WHICH THE GRANT WAS MADE.</ResultsOfVerificationTxt>
      </ExpenditureResponsibilityGrp>
      <ExpenditureResponsibilityGrp>
        <BusinessName>
          <BusinessNameLine1Txt>ST VINCENT'S INSTITUTE FOR MEDICAL RESEARCH</BusinessNameLine1Txt>
        </BusinessName>
        <ForeignAddress>
          <AddressLine1Txt>9 PRINCES STREET</AddressLine1Txt>
          <CityNm>FITZROY</CityNm>
          <CountryCd>AS</CountryCd>
          <ForeignPostalCd>3065</ForeignPostalCd>
        </ForeignAddress>
        <GrantDt>2023-10-18</GrantDt>
        <GrantAmt>54070</GrantAmt>
        <PurposeOfGrantTxt>RESEARCH PROPOSAL - INVESTIGATING A FUNCTIONALLY IMPORTANT POPULATION OF IMMUNE CELLS AS ABIOMARKER AND POTENTIAL THERAPEUTIC TARGET IN LIPEDEMA</PurposeOfGrantTxt>
        <ExpendedByGranteeAmt>0</ExpendedByGranteeAmt>
        <AnyDiversionByGranteeTxt>NO</AnyDiversionByGranteeTxt>
        <ResultsOfVerificationTxt>THE EXPENDITURE RESPONSIBILITY REPORT HAS NOT YET BEEN RECEIVED FROM THE GRANTEE ORGANIZATION AS OF THE DUE DATE OF THE RETURN. TO THE KNOWLEDGE OF THE FOUNDATION, THE GRANTEE HAS NOT DIVERTED ANY PORTION OF THE GRANTS FROM THE PURPOSE FOR WHICH THE GRANT WAS MADE.</ResultsOfVerificationTxt>
      </ExpenditureResponsibilityGrp>
      <ExpenditureResponsibilityGrp>
        <BusinessName>
          <BusinessNameLine1Txt>KLINIKUM ERNST VON BERGMANN GEMEINNUTZIGE GMBH</BusinessNameLine1Txt>
        </BusinessName>
        <ForeignAddress>
          <AddressLine1Txt>CHARLOTTENSTRAE 72</AddressLine1Txt>
          <CityNm>POTSDAM</CityNm>
          <CountryCd>GM</CountryCd>
          <ForeignPostalCd>14467</ForeignPostalCd>
        </ForeignAddress>
        <GrantDt>2023-09-12</GrantDt>
        <GrantAmt>148186</GrantAmt>
        <PurposeOfGrantTxt>RESEARCH PROPOSAL - ASSESSMENT OF GENE EXPRESSION-BASED MOLECULAR BIOMARKERS FOR LIPEDEMA DIAGNOSIS</PurposeOfGrantTxt>
        <ExpendedByGranteeAmt>0</ExpendedByGranteeAmt>
        <AnyDiversionByGranteeTxt>NO</AnyDiversionByGranteeTxt>
        <ResultsOfVerificationTxt>THE EXPENDITURE RESPONSIBILITY REPORT HAS NOT YET BEEN RECEIVED FROM THE GRANTEE ORGANIZATION AS OF THE DUE DATE OF THE RETURN. TO THE KNOWLEDGE OF THE FOUNDATION, THE GRANTEE HAS NOT DIVERTED ANY PORTION OF THE GRANTS FROM THE PURPOSE FOR WHICH THE GRANT WAS MADE.</ResultsOfVerificationTxt>
      </ExpenditureResponsibilityGrp>
      <ExpenditureResponsibilityGrp>
        <BusinessName>
          <BusinessNameLine1Txt>UNIVERSITY HOSPITAL COLOGNE</BusinessNameLine1Txt>
        </BusinessName>
        <ForeignAddress>
          <AddressLine1Txt>JOSEPH-STELTZMANN - STR 9</AddressLine1Txt>
          <CityNm>COLOGNE</CityNm>
          <CountryCd>GM</CountryCd>
          <ForeignPostalCd>50931</ForeignPostalCd>
        </ForeignAddress>
        <GrantDt>2023-08-30</GrantDt>
        <GrantAmt>21412</GrantAmt>
        <PurposeOfGrantTxt>RESEARCH PROPOSAL - IDENTIFICATION OF LIPEDEMA-PAIN SPECIFIC SENSORY MEASURES AS BASIS FORFUTURE DIAGNOSTICS</PurposeOfGrantTxt>
        <ExpendedByGranteeAmt>0</ExpendedByGranteeAmt>
        <AnyDiversionByGranteeTxt>NO</AnyDiversionByGranteeTxt>
        <ResultsOfVerificationTxt>THE EXPENDITURE RESPONSIBILITY REPORT HAS NOT YET BEEN RECEIVED FROM THE GRANTEE ORGANIZATION AS OF THE DUE DATE OF THE RETURN. TO THE KNOWLEDGE OF THE FOUNDATION, THE GRANTEE HAS NOT DIVERTED ANY PORTION OF THE GRANTS FROM THE PURPOSE FOR WHICH THE GRANT WAS MADE.</ResultsOfVerificationTxt>
      </ExpenditureResponsibilityGrp>
      <ExpenditureResponsibilityGrp>
        <BusinessName>
          <BusinessNameLine1Txt>UNIVERSITY OF PADOVA</BusinessNameLine1Txt>
        </BusinessName>
        <ForeignAddress>
          <AddressLine1Txt>VIA GIUSTINIIANI N 2</AddressLine1Txt>
          <CityNm>PADOVA</CityNm>
          <CountryCd>IT</CountryCd>
          <ForeignPostalCd>35128</ForeignPostalCd>
        </ForeignAddress>
        <GrantDt>2023-08-02</GrantDt>
        <GrantAmt>140346</GrantAmt>
        <PurposeOfGrantTxt>RESEARCH PROPOSAL - ROLE OF FASCIAL ALTERATIONS IN LIPEDEMA</PurposeOfGrantTxt>
        <ExpendedByGranteeAmt>0</ExpendedByGranteeAmt>
        <AnyDiversionByGranteeTxt>NO</AnyDiversionByGranteeTxt>
        <ResultsOfVerificationTxt>THE EXPENDITURE RESPONSIBILITY REPORT HAS NOT YET BEEN RECEIVED FROM THE GRANTEE ORGANIZATION AS OF THE DUE DATE OF THE RETURN. TO THE KNOWLEDGE OF THE FOUNDATION, THE GRANTEE HAS NOT DIVERTED ANY PORTION OF THE GRANTS FROM THE PURPOSE FOR WHICH THE GRANT WAS MADE.</ResultsOfVerificationTxt>
      </ExpenditureResponsibilityGrp>
      <ExpenditureResponsibilityGrp>
        <BusinessName>
          <BusinessNameLine1Txt>MACQUARIE UNIVERSITY</BusinessNameLine1Txt>
        </BusinessName>
        <ForeignAddress>
          <AddressLine1Txt>75 TALAVERA RD LEVEL 1</AddressLine1Txt>
          <CityNm>SYDNEY</CityNm>
          <CountryCd>AS</CountryCd>
          <ForeignPostalCd>2019</ForeignPostalCd>
        </ForeignAddress>
        <GrantDt>2023-05-24</GrantDt>
        <GrantAmt>127802</GrantAmt>
        <PurposeOfGrantTxt>RESEARCH PROPOSAL - UTILIZING INDOCYANINE GREEN LYMPHOGRAPHY (ICG) AND BIOIMPEDANCESPECTROSCOPY (BIS) TO UNDERSTAND LIPEDEMA DIAGNOSIS IN COMPARISON TO LYMPHEDEMA AND OBESITY</PurposeOfGrantTxt>
        <ExpendedByGranteeAmt>122976</ExpendedByGranteeAmt>
        <AnyDiversionByGranteeTxt>NO</AnyDiversionByGranteeTxt>
        <DatesOfReportsByGranteeTxt>08/01/2024</DatesOfReportsByGranteeTxt>
        <ResultsOfVerificationTxt>TO THE KNOWLEDGE OF THE FOUNDATION, THE GRANTEE HAS NOT DIVERTED ANY PORTION OF THE GRANTS FROM THE PURPOSE FOR WHICH THE GRANT WAS MADE.</ResultsOfVerificationTxt>
      </ExpenditureResponsibilityGrp>
      <ExpenditureResponsibilityGrp>
        <BusinessName>
          <BusinessNameLine1Txt>LYSEARCH GMBH</BusinessNameLine1Txt>
        </BusinessName>
        <ForeignAddress>
          <AddressLine1Txt>BIBESTR 7</AddressLine1Txt>
          <CityNm>COLOGNE</CityNm>
          <CountryCd>GM</CountryCd>
          <ForeignPostalCd>50678 KLN</ForeignPostalCd>
        </ForeignAddress>
        <GrantDt>2023-08-16</GrantDt>
        <GrantAmt>56201</GrantAmt>
        <PurposeOfGrantTxt>RESEARCH PROPOSAL - HOW DOES BARIATRIC SURGERY AFFECT LIPEDEMA</PurposeOfGrantTxt>
        <ExpendedByGranteeAmt>56201</ExpendedByGranteeAmt>
        <AnyDiversionByGranteeTxt>NO</AnyDiversionByGranteeTxt>
        <DatesOfReportsByGranteeTxt>9/1/24</DatesOfReportsByGranteeTxt>
        <ResultsOfVerificationTxt>TO THE KNOWLEDGE OF THE FOUNDATION, THE GRANTEE HAS NOT DIVERTED ANY PORTION OF THE GRANTS FROM THE PURPOSE FOR WHICH THE GRANT WAS MADE.</ResultsOfVerificationTxt>
      </ExpenditureResponsibilityGrp>
      <ExpenditureResponsibilityGrp>
        <BusinessName>
          <BusinessNameLine1Txt>ST GEORGE'S UNIVERSITY OF LONDON</BusinessNameLine1Txt>
        </BusinessName>
        <ForeignAddress>
          <AddressLine1Txt>CRANMER TERRACE</AddressLine1Txt>
          <CityNm>LONDON</CityNm>
          <CountryCd>UK</CountryCd>
          <ForeignPostalCd>SW17 0RE</ForeignPostalCd>
        </ForeignAddress>
        <GrantDt>2021-11-19</GrantDt>
        <GrantAmt>174856</GrantAmt>
        <PurposeOfGrantTxt>RESEARCH PROPOSAL- DECIPHERING THE GENETIC BASIS OF LIPEDEMA</PurposeOfGrantTxt>
        <ExpendedByGranteeAmt>174856</ExpendedByGranteeAmt>
        <AnyDiversionByGranteeTxt>NO</AnyDiversionByGranteeTxt>
        <DatesOfReportsByGranteeTxt>10/21/2024</DatesOfReportsByGranteeTxt>
        <ResultsOfVerificationTxt>TO THE KNOWLEDGE OF THE FOUNDATION, THE GRANTEE HAS NOT DIVERTED ANY PORTION OF THE GRANTS FROM THE PURPOSE FOR WHICH THE GRANT WAS MADE.</ResultsOfVerificationTxt>
      </ExpenditureResponsibilityGrp>
    </ExpenditureResponsibilityStmt>
    <InvestmentsCorpStockSchedule documentId="RetDoc2018900001">
      <InvestmentsCorporateStockGrp>
        <StockNm>54,280 SHS ALPHABET INC. CLASS A</StockNm>
        <EOYBookValueAmt>7582374</EOYBookValueAmt>
        <EOYFMVAmt>7582374</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>27,100 SHS AMAZON.COM INC.</StockNm>
        <EOYBookValueAmt>4117574</EOYBookValueAmt>
        <EOYFMVAmt>4117574</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>61,595 SHS APPLE INC.</StockNm>
        <EOYBookValueAmt>11858885</EOYBookValueAmt>
        <EOYFMVAmt>11858885</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>10,368 SHS PAYPAL HOLDINGS INCORPOR</StockNm>
        <EOYBookValueAmt>636699</EOYBookValueAmt>
        <EOYFMVAmt>636699</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>15,390 SHS INVESCO QQQ TRUST</StockNm>
        <EOYBookValueAmt>6302513</EOYBookValueAmt>
        <EOYFMVAmt>6302513</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>73,058 SHS SPDR S &amp; P 500 ETF</StockNm>
        <EOYBookValueAmt>34725198</EOYBookValueAmt>
        <EOYFMVAmt>34725198</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>22,746.1345 SHS VANGUARD REAL ESTATE ETF (VNQ)</StockNm>
        <EOYBookValueAmt>2009848</EOYBookValueAmt>
        <EOYFMVAmt>2009848</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>12,000 SHS INTEL CORP</StockNm>
        <EOYBookValueAmt>603000</EOYBookValueAmt>
        <EOYFMVAmt>603000</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
    </InvestmentsCorpStockSchedule>
    <LegalFeesSchedule documentId="RetDoc2002100001">
      <LegalFeesGrp>
        <CategoryTxt>LEGAL FEES IN CONNECTION WITH VARIOUS FOUNDATION MATTERS</CategoryTxt>
        <LegalFeesAmt>29091</LegalFeesAmt>
        <NetInvestmentIncomeAmt>0</NetInvestmentIncomeAmt>
        <DisbursementsCharitablePrpsAmt>29091</DisbursementsCharitablePrpsAmt>
      </LegalFeesGrp>
    </LegalFeesSchedule>
    <OtherAssetsSchedule documentId="RetDoc2046600001">
      <OtherAssetsScheduleGrp>
        <Desc>22C CAPITAL</Desc>
        <BOYBookValueAmt>156559</BOYBookValueAmt>
        <EOYBookValueAmt>269584</EOYBookValueAmt>
        <EOYFMVAmt>269584</EOYFMVAmt>
      </OtherAssetsScheduleGrp>
      <OtherAssetsScheduleGrp>
        <Desc>AXONIC OPPORTUNITIES OFFSHORE</Desc>
        <BOYBookValueAmt>919128</BOYBookValueAmt>
        <EOYBookValueAmt>906040</EOYBookValueAmt>
        <EOYFMVAmt>906040</EOYFMVAmt>
      </OtherAssetsScheduleGrp>
      <OtherAssetsScheduleGrp>
        <Desc>CAZ CO-INVESTMENT OPPORTUNITIES FUND</Desc>
        <BOYBookValueAmt>1493671</BOYBookValueAmt>
        <EOYBookValueAmt>1649557</EOYBookValueAmt>
        <EOYFMVAmt>1649557</EOYFMVAmt>
      </OtherAssetsScheduleGrp>
      <OtherAssetsScheduleGrp>
        <Desc>DIVIDEND RECEIVABLE</Desc>
        <BOYBookValueAmt>0</BOYBookValueAmt>
        <EOYBookValueAmt>108247</EOYBookValueAmt>
        <EOYFMVAmt>108247</EOYFMVAmt>
      </OtherAssetsScheduleGrp>
      <OtherAssetsScheduleGrp>
        <Desc>INVESTMENT - BLACKSTONE REIT</Desc>
        <BOYBookValueAmt>1058619</BOYBookValueAmt>
        <EOYBookValueAmt>6775</EOYBookValueAmt>
        <EOYFMVAmt>6775</EOYFMVAmt>
      </OtherAssetsScheduleGrp>
      <OtherAssetsScheduleGrp>
        <Desc>OWL ROCK CAPITAL</Desc>
        <BOYBookValueAmt>1007694</BOYBookValueAmt>
        <EOYBookValueAmt>1043228</EOYBookValueAmt>
        <EOYFMVAmt>1043228</EOYFMVAmt>
      </OtherAssetsScheduleGrp>
      <OtherAssetsScheduleGrp>
        <Desc>OWL ROCK DIVERSIFIED HOLDINGS</Desc>
        <BOYBookValueAmt>125538</BOYBookValueAmt>
        <EOYBookValueAmt>113888</EOYBookValueAmt>
        <EOYFMVAmt>113888</EOYFMVAmt>
      </OtherAssetsScheduleGrp>
      <OtherAssetsScheduleGrp>
        <Desc>OWL ROCK TECH FINANCE CORP II</Desc>
        <BOYBookValueAmt>580315</BOYBookValueAmt>
        <EOYBookValueAmt>739249</EOYBookValueAmt>
        <EOYFMVAmt>739249</EOYFMVAmt>
      </OtherAssetsScheduleGrp>
      <OtherAssetsScheduleGrp>
        <Desc>OWL ROCK TECH HOLDINGS</Desc>
        <BOYBookValueAmt>52468</BOYBookValueAmt>
        <EOYBookValueAmt>48308</EOYBookValueAmt>
        <EOYFMVAmt>48308</EOYFMVAmt>
      </OtherAssetsScheduleGrp>
      <OtherAssetsScheduleGrp>
        <Desc>RA CAPITAL HEALTHCARE INTL FUND</Desc>
        <BOYBookValueAmt>830906</BOYBookValueAmt>
        <EOYBookValueAmt>1024259</EOYBookValueAmt>
        <EOYFMVAmt>1024259</EOYFMVAmt>
      </OtherAssetsScheduleGrp>
      <OtherAssetsScheduleGrp>
        <Desc>RENAISSANCE ACCESS LLC</Desc>
        <BOYBookValueAmt>1338642</BOYBookValueAmt>
        <EOYBookValueAmt>0</EOYBookValueAmt>
        <EOYFMVAmt>0</EOYFMVAmt>
      </OtherAssetsScheduleGrp>
      <OtherAssetsScheduleGrp>
        <Desc>THE CHILDRENS INVESTMENT FUND</Desc>
        <BOYBookValueAmt>1457900</BOYBookValueAmt>
        <EOYBookValueAmt>0</EOYBookValueAmt>
        <EOYFMVAmt>0</EOYFMVAmt>
      </OtherAssetsScheduleGrp>
    </OtherAssetsSchedule>
    <OtherExpensesSchedule documentId="RetDoc2003200001">
      <OtherExpensesScheduleGrp>
        <Desc>BANK FEE</Desc>
        <RevenueAndExpensesPerBooksAmt>6804</RevenueAndExpensesPerBooksAmt>
        <NetInvestmentIncomeAmt>6804</NetInvestmentIncomeAmt>
        <DisbursementsCharitablePrpsAmt>0</DisbursementsCharitablePrpsAmt>
      </OtherExpensesScheduleGrp>
      <OtherExpensesScheduleGrp>
        <Desc>BROKERAGE/ADVISORY FEES</Desc>
        <RevenueAndExpensesPerBooksAmt>371994</RevenueAndExpensesPerBooksAmt>
        <NetInvestmentIncomeAmt>371994</NetInvestmentIncomeAmt>
        <DisbursementsCharitablePrpsAmt>0</DisbursementsCharitablePrpsAmt>
      </OtherExpensesScheduleGrp>
      <OtherExpensesScheduleGrp>
        <Desc>COMPUTER &amp; INTERNET EXPENSES</Desc>
        <RevenueAndExpensesPerBooksAmt>12441</RevenueAndExpensesPerBooksAmt>
        <NetInvestmentIncomeAmt>0</NetInvestmentIncomeAmt>
        <DisbursementsCharitablePrpsAmt>12441</DisbursementsCharitablePrpsAmt>
      </OtherExpensesScheduleGrp>
      <OtherExpensesScheduleGrp>
        <Desc>CONFERENCES &amp; SPONSORSHIPS</Desc>
        <RevenueAndExpensesPerBooksAmt>50360</RevenueAndExpensesPerBooksAmt>
        <NetInvestmentIncomeAmt>0</NetInvestmentIncomeAmt>
        <DisbursementsCharitablePrpsAmt>50360</DisbursementsCharitablePrpsAmt>
      </OtherExpensesScheduleGrp>
      <OtherExpensesScheduleGrp>
        <Desc>CONSULTING</Desc>
        <RevenueAndExpensesPerBooksAmt>6229</RevenueAndExpensesPerBooksAmt>
        <NetInvestmentIncomeAmt>0</NetInvestmentIncomeAmt>
        <DisbursementsCharitablePrpsAmt>6229</DisbursementsCharitablePrpsAmt>
      </OtherExpensesScheduleGrp>
      <OtherExpensesScheduleGrp>
        <Desc>ELECTRIC</Desc>
        <RevenueAndExpensesPerBooksAmt>1300</RevenueAndExpensesPerBooksAmt>
        <NetInvestmentIncomeAmt>0</NetInvestmentIncomeAmt>
        <DisbursementsCharitablePrpsAmt>1300</DisbursementsCharitablePrpsAmt>
      </OtherExpensesScheduleGrp>
      <OtherExpensesScheduleGrp>
        <Desc>FILING FEES</Desc>
        <RevenueAndExpensesPerBooksAmt>580</RevenueAndExpensesPerBooksAmt>
        <NetInvestmentIncomeAmt>0</NetInvestmentIncomeAmt>
        <DisbursementsCharitablePrpsAmt>580</DisbursementsCharitablePrpsAmt>
      </OtherExpensesScheduleGrp>
      <OtherExpensesScheduleGrp>
        <Desc>FUND EXPENSE</Desc>
        <RevenueAndExpensesPerBooksAmt>36154</RevenueAndExpensesPerBooksAmt>
        <NetInvestmentIncomeAmt>0</NetInvestmentIncomeAmt>
        <DisbursementsCharitablePrpsAmt>36154</DisbursementsCharitablePrpsAmt>
      </OtherExpensesScheduleGrp>
      <OtherExpensesScheduleGrp>
        <Desc>GRANT MANAGEMENT</Desc>
        <RevenueAndExpensesPerBooksAmt>7495</RevenueAndExpensesPerBooksAmt>
        <NetInvestmentIncomeAmt>0</NetInvestmentIncomeAmt>
        <DisbursementsCharitablePrpsAmt>7495</DisbursementsCharitablePrpsAmt>
      </OtherExpensesScheduleGrp>
      <OtherExpensesScheduleGrp>
        <Desc>INSURANCE</Desc>
        <RevenueAndExpensesPerBooksAmt>59413</RevenueAndExpensesPerBooksAmt>
        <NetInvestmentIncomeAmt>0</NetInvestmentIncomeAmt>
        <DisbursementsCharitablePrpsAmt>59413</DisbursementsCharitablePrpsAmt>
      </OtherExpensesScheduleGrp>
      <OtherExpensesScheduleGrp>
        <Desc>IT SUPPORT</Desc>
        <RevenueAndExpensesPerBooksAmt>60520</RevenueAndExpensesPerBooksAmt>
        <NetInvestmentIncomeAmt>0</NetInvestmentIncomeAmt>
        <DisbursementsCharitablePrpsAmt>60520</DisbursementsCharitablePrpsAmt>
      </OtherExpensesScheduleGrp>
      <OtherExpensesScheduleGrp>
        <Desc>LIPEDEMA AWARENESS</Desc>
        <RevenueAndExpensesPerBooksAmt>79177</RevenueAndExpensesPerBooksAmt>
        <NetInvestmentIncomeAmt>0</NetInvestmentIncomeAmt>
        <DisbursementsCharitablePrpsAmt>79177</DisbursementsCharitablePrpsAmt>
      </OtherExpensesScheduleGrp>
      <OtherExpensesScheduleGrp>
        <Desc>MARKETING</Desc>
        <RevenueAndExpensesPerBooksAmt>94920</RevenueAndExpensesPerBooksAmt>
        <NetInvestmentIncomeAmt>0</NetInvestmentIncomeAmt>
        <DisbursementsCharitablePrpsAmt>94920</DisbursementsCharitablePrpsAmt>
      </OtherExpensesScheduleGrp>
      <OtherExpensesScheduleGrp>
        <Desc>MEALS AND ENTERTAINMENT</Desc>
        <RevenueAndExpensesPerBooksAmt>7111</RevenueAndExpensesPerBooksAmt>
        <NetInvestmentIncomeAmt>0</NetInvestmentIncomeAmt>
        <DisbursementsCharitablePrpsAmt>7111</DisbursementsCharitablePrpsAmt>
      </OtherExpensesScheduleGrp>
      <OtherExpensesScheduleGrp>
        <Desc>MEMBERSHIP EXPENSE</Desc>
        <RevenueAndExpensesPerBooksAmt>9249</RevenueAndExpensesPerBooksAmt>
        <NetInvestmentIncomeAmt>0</NetInvestmentIncomeAmt>
        <DisbursementsCharitablePrpsAmt>9249</DisbursementsCharitablePrpsAmt>
      </OtherExpensesScheduleGrp>
      <OtherExpensesScheduleGrp>
        <Desc>MISCELLANEOUS EXPENSE</Desc>
        <RevenueAndExpensesPerBooksAmt>2</RevenueAndExpensesPerBooksAmt>
        <NetInvestmentIncomeAmt>0</NetInvestmentIncomeAmt>
        <DisbursementsCharitablePrpsAmt>2</DisbursementsCharitablePrpsAmt>
      </OtherExpensesScheduleGrp>
      <OtherExpensesScheduleGrp>
        <Desc>OFFICE EXPENSES</Desc>
        <RevenueAndExpensesPerBooksAmt>8592</RevenueAndExpensesPerBooksAmt>
        <NetInvestmentIncomeAmt>0</NetInvestmentIncomeAmt>
        <DisbursementsCharitablePrpsAmt>8592</DisbursementsCharitablePrpsAmt>
      </OtherExpensesScheduleGrp>
      <OtherExpensesScheduleGrp>
        <Desc>PARTNERSHIP DEDUCTIONS - 22C CAPITAL</Desc>
        <RevenueAndExpensesPerBooksAmt>22793</RevenueAndExpensesPerBooksAmt>
        <NetInvestmentIncomeAmt>22793</NetInvestmentIncomeAmt>
        <DisbursementsCharitablePrpsAmt>0</DisbursementsCharitablePrpsAmt>
      </OtherExpensesScheduleGrp>
      <OtherExpensesScheduleGrp>
        <Desc>PARTNERSHIP DEDUCTIONS -CAZ CO-INVESTMENT OPPORTUNITIES FUND</Desc>
        <RevenueAndExpensesPerBooksAmt>4351</RevenueAndExpensesPerBooksAmt>
        <NetInvestmentIncomeAmt>4351</NetInvestmentIncomeAmt>
        <DisbursementsCharitablePrpsAmt>0</DisbursementsCharitablePrpsAmt>
      </OtherExpensesScheduleGrp>
      <OtherExpensesScheduleGrp>
        <Desc>PATIENT REGISTRY</Desc>
        <RevenueAndExpensesPerBooksAmt>14503</RevenueAndExpensesPerBooksAmt>
        <NetInvestmentIncomeAmt>0</NetInvestmentIncomeAmt>
        <DisbursementsCharitablePrpsAmt>14503</DisbursementsCharitablePrpsAmt>
      </OtherExpensesScheduleGrp>
      <OtherExpensesScheduleGrp>
        <Desc>PAYROLL PROCESSING FEES</Desc>
        <RevenueAndExpensesPerBooksAmt>24352</RevenueAndExpensesPerBooksAmt>
        <NetInvestmentIncomeAmt>0</NetInvestmentIncomeAmt>
        <DisbursementsCharitablePrpsAmt>24352</DisbursementsCharitablePrpsAmt>
      </OtherExpensesScheduleGrp>
      <OtherExpensesScheduleGrp>
        <Desc>PAYROLL TAXES</Desc>
        <RevenueAndExpensesPerBooksAmt>71785</RevenueAndExpensesPerBooksAmt>
        <NetInvestmentIncomeAmt>0</NetInvestmentIncomeAmt>
        <DisbursementsCharitablePrpsAmt>71785</DisbursementsCharitablePrpsAmt>
      </OtherExpensesScheduleGrp>
      <OtherExpensesScheduleGrp>
        <Desc>PERSONAL PROPERTY TAX</Desc>
        <RevenueAndExpensesPerBooksAmt>2243</RevenueAndExpensesPerBooksAmt>
        <NetInvestmentIncomeAmt>0</NetInvestmentIncomeAmt>
        <DisbursementsCharitablePrpsAmt>2243</DisbursementsCharitablePrpsAmt>
      </OtherExpensesScheduleGrp>
      <OtherExpensesScheduleGrp>
        <Desc>POSTAGE</Desc>
        <RevenueAndExpensesPerBooksAmt>1519</RevenueAndExpensesPerBooksAmt>
        <NetInvestmentIncomeAmt>0</NetInvestmentIncomeAmt>
        <DisbursementsCharitablePrpsAmt>1519</DisbursementsCharitablePrpsAmt>
      </OtherExpensesScheduleGrp>
      <OtherExpensesScheduleGrp>
        <Desc>RECRUITMENT</Desc>
        <RevenueAndExpensesPerBooksAmt>115396</RevenueAndExpensesPerBooksAmt>
        <NetInvestmentIncomeAmt>0</NetInvestmentIncomeAmt>
        <DisbursementsCharitablePrpsAmt>115396</DisbursementsCharitablePrpsAmt>
      </OtherExpensesScheduleGrp>
      <OtherExpensesScheduleGrp>
        <Desc>RESEARCH EXPENSE</Desc>
        <RevenueAndExpensesPerBooksAmt>19850</RevenueAndExpensesPerBooksAmt>
        <NetInvestmentIncomeAmt>0</NetInvestmentIncomeAmt>
        <DisbursementsCharitablePrpsAmt>19850</DisbursementsCharitablePrpsAmt>
      </OtherExpensesScheduleGrp>
      <OtherExpensesScheduleGrp>
        <Desc>RETIREMENT -ADMINISTRATION FEE</Desc>
        <RevenueAndExpensesPerBooksAmt>1530</RevenueAndExpensesPerBooksAmt>
        <NetInvestmentIncomeAmt>0</NetInvestmentIncomeAmt>
        <DisbursementsCharitablePrpsAmt>1530</DisbursementsCharitablePrpsAmt>
      </OtherExpensesScheduleGrp>
      <OtherExpensesScheduleGrp>
        <Desc>SOFTWARE SUBSCRIPTION</Desc>
        <RevenueAndExpensesPerBooksAmt>22259</RevenueAndExpensesPerBooksAmt>
        <NetInvestmentIncomeAmt>0</NetInvestmentIncomeAmt>
        <DisbursementsCharitablePrpsAmt>22259</DisbursementsCharitablePrpsAmt>
      </OtherExpensesScheduleGrp>
      <OtherExpensesScheduleGrp>
        <Desc>TELEPHONE</Desc>
        <RevenueAndExpensesPerBooksAmt>8372</RevenueAndExpensesPerBooksAmt>
        <NetInvestmentIncomeAmt>0</NetInvestmentIncomeAmt>
        <DisbursementsCharitablePrpsAmt>8372</DisbursementsCharitablePrpsAmt>
      </OtherExpensesScheduleGrp>
      <OtherExpensesScheduleGrp>
        <Desc>WEB DEVELOPMENT/HOSTING</Desc>
        <RevenueAndExpensesPerBooksAmt>1626</RevenueAndExpensesPerBooksAmt>
        <NetInvestmentIncomeAmt>0</NetInvestmentIncomeAmt>
        <DisbursementsCharitablePrpsAmt>1626</DisbursementsCharitablePrpsAmt>
      </OtherExpensesScheduleGrp>
    </OtherExpensesSchedule>
    <OtherIncomeSchedule2 documentId="RetDoc2001500001">
      <OtherIncomeDetail>
        <Desc>OTHER INCOME FROM PARTNERSHIPS</Desc>
        <RevenueAndExpensesPerBooksAmt>-910</RevenueAndExpensesPerBooksAmt>
        <NetInvestmentIncomeAmt>-910</NetInvestmentIncomeAmt>
        <AdjustedNetIncomeAmt>-910</AdjustedNetIncomeAmt>
      </OtherIncomeDetail>
      <OtherIncomeDetail>
        <Desc>RECOVERY OF PRIOR YEAR QUALIFYING DISTRIBUTION</Desc>
        <RevenueAndExpensesPerBooksAmt>389</RevenueAndExpensesPerBooksAmt>
        <AdjustedNetIncomeAmt>389</AdjustedNetIncomeAmt>
      </OtherIncomeDetail>
    </OtherIncomeSchedule2>
    <OtherIncreasesSchedule documentId="RetDoc2049700001">
      <OtherIncreasesDetail>
        <Desc>UNREALIZED GAIN/LOSS ON INVESTMENT PORTFOLIO</Desc>
        <Amt>8229688</Amt>
      </OtherIncreasesDetail>
      <OtherIncreasesDetail>
        <Desc>BOOK/TAX ADJUSTMENT ON SALE OF DONATED ASSETS</Desc>
        <Amt>8264947</Amt>
      </OtherIncreasesDetail>
    </OtherIncreasesSchedule>
    <SubstantialContributorsSch documentId="RetDoc2089200001">
      <SubstantialContributorDetail>
        <PersonNm>SUHAS AND FELICITIE DAFTUAR</PersonNm>
        <USAddress>
          <AddressLine1Txt>450 LEXINGTON AVE 38TH FL</AddressLine1Txt>
          <CityNm>NEW YORK</CityNm>
          <StateAbbreviationCd>NY</StateAbbreviationCd>
          <ZIPCd>10017</ZIPCd>
        </USAddress>
      </SubstantialContributorDetail>
      <SubstantialContributorDetail>
        <PersonNm>SUHAS AND FELICITIE DAFTUAR</PersonNm>
        <USAddress>
          <AddressLine1Txt>450 LEXINGTON AVE 38TH FL</AddressLine1Txt>
          <CityNm>NEW YORK</CityNm>
          <StateAbbreviationCd>NY</StateAbbreviationCd>
          <ZIPCd>10017</ZIPCd>
        </USAddress>
      </SubstantialContributorDetail>
      <SubstantialContributorDetail>
        <PersonNm>SUHAS AND FELICITIE DAFTUAR</PersonNm>
        <USAddress>
          <AddressLine1Txt>450 LEXINGTON AVE 38TH FL</AddressLine1Txt>
          <CityNm>NEW YORK</CityNm>
          <StateAbbreviationCd>NY</StateAbbreviationCd>
          <ZIPCd>10017</ZIPCd>
        </USAddress>
      </SubstantialContributorDetail>
      <SubstantialContributorDetail>
        <PersonNm>SUHAS AND FELICITIE DAFTUAR</PersonNm>
        <USAddress>
          <AddressLine1Txt>450 LEXINGTON AVE 38TH FL</AddressLine1Txt>
          <CityNm>NEW YORK</CityNm>
          <StateAbbreviationCd>NY</StateAbbreviationCd>
          <ZIPCd>10017</ZIPCd>
        </USAddress>
      </SubstantialContributorDetail>
      <SubstantialContributorDetail>
        <PersonNm>SUHAS AND FELICITIE DAFTUAR</PersonNm>
        <USAddress>
          <AddressLine1Txt>450 LEXINGTON AVE 38TH FL</AddressLine1Txt>
          <CityNm>NEW YORK</CityNm>
          <StateAbbreviationCd>NY</StateAbbreviationCd>
          <ZIPCd>10017</ZIPCd>
        </USAddress>
      </SubstantialContributorDetail>
      <SubstantialContributorDetail>
        <PersonNm>SUHAS AND FELICITIE DAFTUAR</PersonNm>
        <USAddress>
          <AddressLine1Txt>450 LEXINGTON AVE 38TH FL</AddressLine1Txt>
          <CityNm>NEW YORK</CityNm>
          <StateAbbreviationCd>NY</StateAbbreviationCd>
          <ZIPCd>10017</ZIPCd>
        </USAddress>
      </SubstantialContributorDetail>
      <SubstantialContributorDetail>
        <PersonNm>SUHAS AND FELICITIE DAFTUAR</PersonNm>
        <USAddress>
          <AddressLine1Txt>450 LEXINGTON AVE 38TH FL</AddressLine1Txt>
          <CityNm>NEW YORK</CityNm>
          <StateAbbreviationCd>NY</StateAbbreviationCd>
          <ZIPCd>10017</ZIPCd>
        </USAddress>
      </SubstantialContributorDetail>
      <SubstantialContributorDetail>
        <PersonNm>SUHAS AND FELICITIE DAFTUAR</PersonNm>
        <USAddress>
          <AddressLine1Txt>450 LEXINGTON AVE 38TH FL</AddressLine1Txt>
          <CityNm>NEW YORK</CityNm>
          <StateAbbreviationCd>NY</StateAbbreviationCd>
          <ZIPCd>10017</ZIPCd>
        </USAddress>
      </SubstantialContributorDetail>
      <SubstantialContributorDetail>
        <PersonNm>SUHAS AND FELICITIE DAFTUAR</PersonNm>
        <USAddress>
          <AddressLine1Txt>450 LEXINGTON AVE 38TH FL</AddressLine1Txt>
          <CityNm>NEW YORK</CityNm>
          <StateAbbreviationCd>NY</StateAbbreviationCd>
          <ZIPCd>10017</ZIPCd>
        </USAddress>
      </SubstantialContributorDetail>
      <SubstantialContributorDetail>
        <PersonNm>SUHAS AND FELICITIE DAFTUAR</PersonNm>
        <USAddress>
          <AddressLine1Txt>450 LEXINGTON AVE 38TH FL</AddressLine1Txt>
          <CityNm>NEW YORK</CityNm>
          <StateAbbreviationCd>NY</StateAbbreviationCd>
          <ZIPCd>10017</ZIPCd>
        </USAddress>
      </SubstantialContributorDetail>
      <SubstantialContributorDetail>
        <PersonNm>SUHAS AND FELICITIE DAFTUAR</PersonNm>
        <USAddress>
          <AddressLine1Txt>450 LEXINGTON AVE 38TH FL</AddressLine1Txt>
          <CityNm>NEW YORK</CityNm>
          <StateAbbreviationCd>NY</StateAbbreviationCd>
          <ZIPCd>10017</ZIPCd>
        </USAddress>
      </SubstantialContributorDetail>
      <SubstantialContributorDetail>
        <PersonNm>SUHAS AND FELICITIE DAFTUAR</PersonNm>
        <USAddress>
          <AddressLine1Txt>450 LEXINGTON AVE 38TH FL</AddressLine1Txt>
          <CityNm>NEW YORK</CityNm>
          <StateAbbreviationCd>NY</StateAbbreviationCd>
          <ZIPCd>10017</ZIPCd>
        </USAddress>
      </SubstantialContributorDetail>
      <SubstantialContributorDetail>
        <PersonNm>ROBERT THOMPSON</PersonNm>
        <USAddress>
          <AddressLine1Txt>2424 41ST STREET</AddressLine1Txt>
          <CityNm>MOLINE</CityNm>
          <StateAbbreviationCd>IL</StateAbbreviationCd>
          <ZIPCd>61265</ZIPCd>
        </USAddress>
      </SubstantialContributorDetail>
    </SubstantialContributorsSch>
    <TaxesSchedule documentId="RetDoc2002500001">
      <TaxesDetail>
        <CategoryTxt>FEDERAL EXCISE TAX ON NET INVESTMENT INCOME</CategoryTxt>
        <Amt>70000</Amt>
        <NetInvestmentIncomeAmt>0</NetInvestmentIncomeAmt>
        <DisbursementsCharitablePrpsAmt>0</DisbursementsCharitablePrpsAmt>
      </TaxesDetail>
    </TaxesSchedule>
  </ReturnData>
</Return>